<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2026"
  xmlns:figxu="http://figx.com/20260331"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2026"
  xmlns:us-gaap="http://fasb.org/us-gaap/2026"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="figxu-20260331.xsd" xlink:type="simple"/>
    <context id="cref_2073882789">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1165240187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
        </entity>
        <period>
            <startDate>2025-02-20</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_1744689869">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_590850699">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1980527220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_1710269123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputSharePriceMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_1119542603">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputRiskFreeInterestRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_645954474">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputOptionVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_1624330424">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
        </entity>
        <period>
            <startDate>2025-06-30</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_318541363">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1443541773">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1217455353">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_718551497">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_258509850">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_251878526">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_408691691">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_2104595459">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">figxu:PrivatePlacementWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1686745824">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">figxu:PublicWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_68441282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1780687913">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1373974908">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_494142625">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_325383437">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_746723642">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_423467157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">figxu:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_874436487">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">figxu:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1940954079">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">figxu:UnderwritingAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1702843046">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="cref_391051224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">figxu:PostBusinessCombinationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1062453623">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_214983395">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">srt:ChiefFinancialOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-09-01</startDate>
            <endDate>2025-09-01</endDate>
        </period>
    </context>
    <context id="cref_89425586">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_34845724">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1120564630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
        </entity>
        <period>
            <startDate>2026-06-27</startDate>
            <endDate>2026-06-27</endDate>
        </period>
    </context>
    <context id="cref_1782949702">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">figxu:IPOPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:RelatedPartyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_284125506">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">figxu:IPOPromissoryNoteMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1243115437">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
        </entity>
        <period>
            <startDate>2025-05-31</startDate>
            <endDate>2025-05-31</endDate>
        </period>
    </context>
    <context id="cref_1121590045">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">figxu:FounderShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-31</instant>
        </period>
    </context>
    <context id="cref_1172863110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">figxu:InitialBusinessCombinationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-31</startDate>
            <endDate>2025-05-31</endDate>
        </period>
    </context>
    <context id="cref_1588645818">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">figxu:FounderShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-31</startDate>
            <endDate>2025-05-31</endDate>
        </period>
    </context>
    <context id="cref_1976653253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">figxu:FounderShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">figxu:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-05-31</startDate>
            <endDate>2025-05-31</endDate>
        </period>
    </context>
    <context id="cref_326555146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">figxu:FounderShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">figxu:SponsorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-05-31</instant>
        </period>
    </context>
    <context id="cref_2026176110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">figxu:FounderShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-30</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_842610705">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">figxu:FounderShareMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-27</startDate>
            <endDate>2025-02-27</endDate>
        </period>
    </context>
    <context id="cref_973616570">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">figxu:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-27</instant>
        </period>
    </context>
    <context id="cref_341322038">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">figxu:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-27</startDate>
            <endDate>2025-02-27</endDate>
        </period>
    </context>
    <context id="cref_993633427">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">figxu:PrivatePlacementWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1794589647">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">figxu:PrivatePlacementWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_479841610">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_346691114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_137234818">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">figxu:PublicWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-30</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_2094522727">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">figxu:PublicWarrantMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_602195142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">figxu:PublicWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_193269061">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-30</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1229833713">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-30</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1953066301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_2044206887">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">figxu:PrivateWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_2045073809">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">figxu:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1385100879">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">figxu:ClassBNonRedeemableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-20</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_716079242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">figxu:ClassBNonRedeemableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_352539731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">figxu:ClassARedeemableAndNonRedeemableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1776448153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">figxu:PostBusinessCombinationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_90591216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">figxu:PublicShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_89960868">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">figxu:BusinessCombinationAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1718174532">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_868657012">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">figxu:TrustAccountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_655433440">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">figxu:TrustAccountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-30</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_416625089">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">figxu:PostBusinessCombinationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_2023810708">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_658539131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">figxu:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_1656677855">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">figxu:CantorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-30</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_87242767">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">figxu:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-30</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1265031843">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-30</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_1577398097">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">figxu:SponsorMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:PrivatePlacementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_1194647520">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">figxu:FIGXAcquisitionPartnersLLMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-06-30</instant>
        </period>
    </context>
    <context id="cref_876891952">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BusinessAcquisitionAxis">figxu:FIGXAcquisitionPartnersLLMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-06-30</startDate>
            <endDate>2025-06-30</endDate>
        </period>
    </context>
    <context id="cref_686673142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">figxu:FounderShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_650794531">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="cref_1990009149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="cref_662933581">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="cref_766315599">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <context id="cref_1076052647">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-20</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_1632373075">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-20</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_912874889">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-20</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_697399911">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1922201456">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_1420044896">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_922302944">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_856585502">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_138730714">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1977391001">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1988514580">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:OverAllotmentOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-20</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_214402000">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-20</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_1077322417">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-05</instant>
        </period>
    </context>
    <context id="cref_633137699">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-05-05</instant>
        </period>
    </context>
    <context id="cref_836070148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">figxu:WarrantsEachWholeWarrantExercisableForOneClassAOrdinaryShareAtAnExercisePriceOf1150PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_466315214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">figxu:ClassAOrdinarySharesParValue00001PerShareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1139566100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">figxu:UnitsEachConsistingOfOneClassAOrdinaryShareAndOnehalfOfOneRedeemableWarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1026808960">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-20</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_285628536">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
        </entity>
        <period>
            <instant>2025-02-19</instant>
        </period>
    </context>
    <context id="cref_29103227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">figxu:ClassARedeemableAndNonRedeemableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-20</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_662228944">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-12-31</instant>
        </period>
    </context>
    <context id="cref_1035847545">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_554136025">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1089991393">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2026-01-01</startDate>
            <endDate>2026-03-31</endDate>
        </period>
    </context>
    <context id="cref_1646686479">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2026-03-31</instant>
        </period>
    </context>
    <context id="cref_760626063">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-19</instant>
        </period>
    </context>
    <context id="cref_1057919278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-19</instant>
        </period>
    </context>
    <context id="cref_674229787">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-19</instant>
        </period>
    </context>
    <context id="cref_562583544">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-02-19</instant>
        </period>
    </context>
    <context id="cref_694439886">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-02-20</startDate>
            <endDate>2025-03-31</endDate>
        </period>
    </context>
    <context id="cref_1461372138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0002059033</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2025-03-31</instant>
        </period>
    </context>
    <unit id="uref_782852322">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="uref_367292527">
        <measure>figxu:Segment</measure>
    </unit>
    <unit id="uref_1980527220">
        <measure>pure</measure>
    </unit>
    <unit id="uref_1624330424">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="uref_1643728509">
        <measure>shares</measure>
    </unit>
    <us-gaap:OtherBorrowings
      contextRef="cref_590850699"
      id="fc_577268480"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <dei:EntityTaxIdentificationNumber contextRef="cref_2073882789" id="fc_1929592421">00-0000000</dei:EntityTaxIdentificationNumber>
    <us-gaap:CommitmentsAndContingencies
      contextRef="cref_1744689869"
      id="fc_110316278"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="cref_1744689869"
      id="fc_129230194"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="cref_1744689869"
      id="fc_101649111"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_1744689869"
      id="fc_921070139"
      unitRef="uref_1643728509"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_1744689869"
      id="fc_1769969155"
      unitRef="uref_1643728509"
      xsi:nil="true"/>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_1165240187"
      id="fc_1578970752"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="cref_1165240187"
      id="fc_57099286"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1026808960"
      id="fc_1026808960"
      unitRef="uref_1643728509"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1026808960"
      id="fc_1865421956"
      unitRef="uref_1643728509"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1026808960"
      id="fc_2089031921"
      unitRef="uref_1624330424"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1026808960"
      id="fc_345169237"
      unitRef="uref_1624330424"
      xsi:nil="true"/>
    <us-gaap:CostsAndExpensesRelatedParty
      contextRef="cref_2073882789"
      id="fc_878912755"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_1165240187"
      id="fc_1669601354"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="cref_1165240187"
      id="fc_1819408511"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="cref_1165240187"
      id="fc_848891060"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="cref_1165240187"
      id="fc_1053160133"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_285628536"
      id="fc_285628536"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_650794531"
      id="fc_1134652961"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <figxu:OfferingCostsIncludedInAccruedOfferingCosts
      contextRef="cref_2073882789"
      id="fc_781107994"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <figxu:OfferingCostsPaidThroughPromissoryNoteRelatedParty
      contextRef="cref_2073882789"
      id="fc_1591613886"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_29103227"
      id="fc_29103227"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_29103227"
      id="fc_1382390127"
      unitRef="uref_1643728509"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_29103227"
      id="fc_1734056557"
      unitRef="uref_1624330424"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="cref_29103227"
      id="fc_560032873"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_29103227"
      id="fc_386513161"
      unitRef="uref_1643728509"
      xsi:nil="true"/>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_29103227"
      id="fc_555863419"
      unitRef="uref_1624330424"
      xsi:nil="true"/>
    <us-gaap:AdministrativeFeesExpense
      contextRef="cref_1165240187"
      id="fc_1900016742"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="cref_1165240187"
      id="fc_1904871896"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_1165240187"
      id="fc_1298709857"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_662228944"
      id="fc_662228944"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1035847545"
      id="fc_1035847545"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_554136025"
      id="fc_554136025"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1089991393"
      id="fc_1089991393"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1035847545"
      id="fc_1136251708"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_554136025"
      id="fc_1460485326"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1089991393"
      id="fc_167797707"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_1646686479"
      id="fc_1646686479"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_760626063"
      id="fc_760626063"
      unitRef="uref_1643728509"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_760626063"
      id="fc_714702683"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_1057919278"
      id="fc_1057919278"
      unitRef="uref_1643728509"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_1057919278"
      id="fc_259249065"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_674229787"
      id="fc_674229787"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_562583544"
      id="fc_562583544"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_285628536"
      id="fc_165469009"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_694439886"
      id="fc_694439886"
      unitRef="uref_1643728509"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_694439886"
      id="fc_2081896306"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1076052647"
      id="fc_96955351"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_694439886"
      id="fc_839599154"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_912874889"
      id="fc_826072740"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1632373075"
      id="fc_323869229"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:SharesOutstanding
      contextRef="cref_1461372138"
      id="fc_1461372138"
      unitRef="uref_1643728509"
      xsi:nil="true"/>
    <us-gaap:StockholdersEquity
      contextRef="cref_1461372138"
      id="fc_619286150"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="cref_1165240187"
      id="fc_249122569"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_590850699"
      id="fc_972610273"
      unitRef="uref_1643728509"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_1744689869"
      id="fc_927666548"
      unitRef="uref_1643728509"
      xsi:nil="true"/>
    <us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration contextRef="cref_2073882789" id="fc_665619345">http://fasb.org/srt/2026#ChiefExecutiveOfficerMember</us-gaap:SegmentReportingCodmIndividualTitleAndPositionOrGroupOrCommitteeNameExtensibleEnumeration>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="cref_590850699"
      id="fc_1747469282"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:IncomeTaxExaminationPenaltiesAndInterestExpense
      contextRef="cref_2073882789"
      id="fc_332762307"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:PreferredStockValue
      contextRef="cref_590850699"
      id="fc_1163411756"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:AdditionalPaidInCapital
      contextRef="cref_590850699"
      id="fc_2146577331"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="cref_590850699"
      id="fc_445859941"
      unitRef="uref_782852322"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesIssued
      contextRef="cref_590850699"
      id="fc_1906729548"
      unitRef="uref_1643728509"
      xsi:nil="true"/>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="cref_590850699"
      id="fc_83354851"
      unitRef="uref_1643728509"
      xsi:nil="true"/>
    <dei:AmendmentFlag contextRef="cref_2073882789" id="ixv-3877">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="cref_2073882789" id="ixv-3878">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="cref_2073882789" id="ixv-3879">0002059033</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate contextRef="cref_2073882789" id="ixv-3880">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentType contextRef="cref_2073882789" id="ixv-4752">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport contextRef="cref_2073882789" id="ixv-4753">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate contextRef="cref_2073882789" id="ixv-4754">2026-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus contextRef="cref_2073882789" id="ixv-4755">2026</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport contextRef="cref_2073882789" id="ixv-4756">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="cref_2073882789" id="ixv-4757">001-42719</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="cref_2073882789" id="ixv-4758">FIGX Capital Acquisition Corp.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="cref_2073882789" id="ixv-4759">E9</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1 contextRef="cref_2073882789" id="ixv-4760">428 Greenwood Beach Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="cref_2073882789" id="ixv-4761">Tiburon</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="cref_2073882789" id="ixv-4762">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="cref_2073882789" id="ixv-4763">94920</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="cref_2073882789" id="ixv-4764">(415)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="cref_2073882789" id="ixv-4765">383-1464</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="cref_1139566100" id="ixv-4766">Units, each consisting of one Class A Ordinary Share and one-half of one redeemable Warrant</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_1139566100" id="ixv-4767">FIGXU</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="cref_1139566100" id="ixv-4768">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="cref_466315214" id="ixv-4769">Class A Ordinary Shares, par value $0.0001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_466315214" id="ixv-4770">FIGX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="cref_466315214" id="ixv-4771">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="cref_836070148" id="ixv-4772">Redeemable Warrants, each whole Warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="cref_836070148" id="ixv-4773">FIGXW</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="cref_836070148" id="ixv-4774">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus contextRef="cref_2073882789" id="ixv-4775">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="cref_2073882789" id="ixv-4776">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="cref_2073882789" id="ixv-4777">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="cref_2073882789" id="ixv-4778">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="cref_2073882789" id="ixv-4779">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="cref_2073882789" id="ixv-4780">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany contextRef="cref_2073882789" id="ixv-4781">true</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="cref_633137699"
      decimals="0"
      id="ixv-4782"
      unitRef="uref_1643728509">15508470</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="cref_1077322417"
      decimals="0"
      id="ixv-4783"
      unitRef="uref_1643728509">3877118</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Cash
      contextRef="cref_590850699"
      decimals="0"
      id="ixv-4784"
      unitRef="uref_782852322">858098</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="cref_1744689869"
      decimals="0"
      id="ixv-4785"
      unitRef="uref_782852322">905141</us-gaap:Cash>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="cref_590850699"
      decimals="0"
      id="ixv-4786"
      unitRef="uref_782852322">69838</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="cref_1744689869"
      decimals="0"
      id="ixv-4787"
      unitRef="uref_782852322">71838</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="cref_590850699"
      decimals="0"
      id="ixv-4788"
      unitRef="uref_782852322">927936</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="cref_1744689869"
      decimals="0"
      id="ixv-4789"
      unitRef="uref_782852322">976979</us-gaap:AssetsCurrent>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="cref_590850699"
      decimals="0"
      id="ixv-4790"
      unitRef="uref_782852322">16959</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:PrepaidExpenseNoncurrent
      contextRef="cref_1744689869"
      decimals="0"
      id="ixv-4791"
      unitRef="uref_782852322">33919</us-gaap:PrepaidExpenseNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_590850699"
      decimals="0"
      id="ixv-4792"
      unitRef="uref_782852322">155087314</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_1744689869"
      decimals="0"
      id="ixv-4793"
      unitRef="uref_782852322">153708127</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:Assets
      contextRef="cref_590850699"
      decimals="0"
      id="ixv-4794"
      unitRef="uref_782852322">156032209</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="cref_1744689869"
      decimals="0"
      id="ixv-4795"
      unitRef="uref_782852322">154719025</us-gaap:Assets>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="cref_590850699"
      decimals="0"
      id="ixv-4796"
      unitRef="uref_782852322">105855</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="cref_1744689869"
      decimals="0"
      id="ixv-4797"
      unitRef="uref_782852322">17860</us-gaap:AccruedLiabilitiesCurrent>
    <figxu:AccruedOfferingCosts
      contextRef="cref_590850699"
      decimals="0"
      id="ixv-4798"
      unitRef="uref_782852322">85000</figxu:AccruedOfferingCosts>
    <figxu:AccruedOfferingCosts
      contextRef="cref_1744689869"
      decimals="0"
      id="ixv-4799"
      unitRef="uref_782852322">85000</figxu:AccruedOfferingCosts>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="cref_34845724"
      decimals="0"
      id="ixv-4800"
      unitRef="uref_782852322">4259</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="cref_89425586"
      decimals="0"
      id="ixv-4801"
      unitRef="uref_782852322">1943</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="cref_590850699"
      decimals="0"
      id="ixv-4802"
      unitRef="uref_782852322">195114</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="cref_1744689869"
      decimals="0"
      id="ixv-4803"
      unitRef="uref_782852322">104804</us-gaap:LiabilitiesCurrent>
    <figxu:DeferredUnderwritingFee
      contextRef="cref_590850699"
      decimals="0"
      id="ixv-4804"
      unitRef="uref_782852322">6419000</figxu:DeferredUnderwritingFee>
    <figxu:DeferredUnderwritingFee
      contextRef="cref_1744689869"
      decimals="0"
      id="ixv-4805"
      unitRef="uref_782852322">6419000</figxu:DeferredUnderwritingFee>
    <us-gaap:Liabilities
      contextRef="cref_590850699"
      decimals="0"
      id="ixv-4806"
      unitRef="uref_782852322">6614114</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="cref_1744689869"
      decimals="0"
      id="ixv-4807"
      unitRef="uref_782852322">6523803</us-gaap:Liabilities>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="cref_325383437"
      decimals="0"
      id="ixv-4808"
      unitRef="uref_1643728509">15065000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="cref_746723642"
      decimals="0"
      id="ixv-4809"
      unitRef="uref_1643728509">15065000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="cref_325383437"
      decimals="2"
      id="ixv-4810"
      unitRef="uref_1624330424">10.29</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityRedemptionPricePerShare
      contextRef="cref_746723642"
      decimals="2"
      id="ixv-4811"
      unitRef="uref_1624330424">10.2</us-gaap:TemporaryEquityRedemptionPricePerShare>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_590850699"
      decimals="0"
      id="ixv-4812"
      unitRef="uref_782852322">155087315</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_1744689869"
      decimals="0"
      id="ixv-4813"
      unitRef="uref_782852322">153708128</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="cref_590850699"
      decimals="4"
      id="fc_658872155"
      unitRef="uref_1624330424">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="cref_1744689869"
      decimals="4"
      id="ixv-4815"
      unitRef="uref_1624330424">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_590850699"
      decimals="0"
      id="ixv-4816"
      unitRef="uref_1643728509">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_1744689869"
      decimals="0"
      id="ixv-4817"
      unitRef="uref_1643728509">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_325383437"
      decimals="4"
      id="ixv-4818"
      unitRef="uref_1624330424">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_746723642"
      decimals="4"
      id="ixv-4819"
      unitRef="uref_1624330424">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_325383437"
      decimals="0"
      id="ixv-4820"
      unitRef="uref_1643728509">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_746723642"
      decimals="0"
      id="ixv-4821"
      unitRef="uref_1643728509">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_325383437"
      decimals="0"
      id="ixv-4822"
      unitRef="uref_1643728509">443470</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_325383437"
      decimals="0"
      id="ixv-4823"
      unitRef="uref_1643728509">443470</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_746723642"
      decimals="0"
      id="ixv-4824"
      unitRef="uref_1643728509">443470</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_746723642"
      decimals="0"
      id="ixv-4825"
      unitRef="uref_1643728509">443470</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="cref_325383437"
      decimals="0"
      id="ixv-4826"
      unitRef="uref_782852322">44</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="cref_746723642"
      decimals="0"
      id="ixv-4827"
      unitRef="uref_782852322">44</us-gaap:CommonStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_494142625"
      decimals="4"
      id="ixv-4828"
      unitRef="uref_1624330424">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_1373974908"
      decimals="4"
      id="ixv-4829"
      unitRef="uref_1624330424">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_494142625"
      decimals="0"
      id="ixv-4830"
      unitRef="uref_1643728509">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_1373974908"
      decimals="0"
      id="ixv-4831"
      unitRef="uref_1643728509">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_494142625"
      decimals="0"
      id="ixv-4832"
      unitRef="uref_1643728509">3877118</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_494142625"
      decimals="0"
      id="ixv-4833"
      unitRef="uref_1643728509">3877118</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_1373974908"
      decimals="0"
      id="ixv-4834"
      unitRef="uref_1643728509">3877118</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_1373974908"
      decimals="0"
      id="ixv-4835"
      unitRef="uref_1643728509">3877118</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="cref_494142625"
      decimals="0"
      id="ixv-4836"
      unitRef="uref_782852322">388</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="cref_1373974908"
      decimals="0"
      id="ixv-4837"
      unitRef="uref_782852322">388</us-gaap:CommonStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="cref_590850699"
      decimals="0"
      id="ixv-4838"
      unitRef="uref_782852322">-5669652</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="cref_1744689869"
      decimals="0"
      id="ixv-4839"
      unitRef="uref_782852322">-5513338</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="cref_590850699"
      decimals="0"
      id="ixv-4840"
      unitRef="uref_782852322">-5669220</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1744689869"
      decimals="0"
      id="ixv-4841"
      unitRef="uref_782852322">-5512906</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="cref_590850699"
      decimals="0"
      id="ixv-4842"
      unitRef="uref_782852322">156032209</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="cref_1744689869"
      decimals="0"
      id="ixv-4843"
      unitRef="uref_782852322">154719025</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_2073882789"
      decimals="0"
      id="ixv-4844"
      unitRef="uref_782852322">156314</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_1165240187"
      decimals="0"
      id="ixv-4845"
      unitRef="uref_782852322">30298</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_2073882789"
      decimals="0"
      id="ixv-4846"
      unitRef="uref_782852322">-156314</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="cref_1165240187"
      decimals="0"
      id="ixv-4847"
      unitRef="uref_782852322">-30298</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_2073882789"
      decimals="0"
      id="ixv-4848"
      unitRef="uref_782852322">1379187</us-gaap:InvestmentIncomeInterest>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="cref_2073882789"
      decimals="0"
      id="ixv-4849"
      unitRef="uref_782852322">1379187</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="cref_2073882789"
      decimals="0"
      id="ixv-4850"
      unitRef="uref_782852322">1222873</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1165240187"
      decimals="0"
      id="ixv-4851"
      unitRef="uref_782852322">-30298</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_718551497"
      decimals="0"
      id="ixv-4852"
      unitRef="uref_1643728509">15508470</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_718551497"
      decimals="0"
      id="ixv-4853"
      unitRef="uref_1643728509">15508470</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_718551497"
      decimals="2"
      id="ixv-4854"
      unitRef="uref_1624330424">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_718551497"
      decimals="2"
      id="ixv-4855"
      unitRef="uref_1624330424">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1780687913"
      decimals="0"
      id="fc_1268699674"
      unitRef="uref_1643728509">3877118</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1780687913"
      decimals="0"
      id="ixv-4857"
      unitRef="uref_1643728509">3877118</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_214402000"
      decimals="0"
      id="fc_864241666"
      unitRef="uref_1643728509">3385868</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_214402000"
      decimals="0"
      id="ixv-4859"
      unitRef="uref_1643728509">3385868</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1780687913"
      decimals="2"
      id="ixv-4860"
      unitRef="uref_1624330424">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1780687913"
      decimals="2"
      id="ixv-4861"
      unitRef="uref_1624330424">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_214402000"
      decimals="2"
      id="ixv-4862"
      unitRef="uref_1624330424">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_214402000"
      decimals="2"
      id="ixv-4863"
      unitRef="uref_1624330424">-0.01</us-gaap:EarningsPerShareDiluted>
    <figxu:OrdinarySharesSubjectToForfeiture
      contextRef="cref_1988514580"
      decimals="0"
      id="ixv-4865"
      unitRef="uref_1643728509">491250</figxu:OrdinarySharesSubjectToForfeiture>
    <figxu:UnitIssuedDuringPeriodShareNewIssues
      contextRef="cref_193269061"
      decimals="0"
      id="ixv-4866"
      unitRef="uref_1643728509">15065000</figxu:UnitIssuedDuringPeriodShareNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1953066301"
      decimals="2"
      id="ixv-4867"
      unitRef="uref_1624330424">10</us-gaap:SharesIssuedPricePerShare>
    <figxu:UnitIssuedDuringPeriodShareNewIssues
      contextRef="cref_1229833713"
      decimals="0"
      id="ixv-4868"
      unitRef="uref_1643728509">491250</figxu:UnitIssuedDuringPeriodShareNewIssues>
    <us-gaap:SharesOutstanding
      contextRef="cref_1977391001"
      decimals="0"
      id="ixv-4869"
      unitRef="uref_1643728509">443470</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_1977391001"
      decimals="0"
      id="ixv-4870"
      unitRef="uref_782852322">44</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="cref_138730714"
      decimals="0"
      id="ixv-4871"
      unitRef="uref_1643728509">3877118</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_138730714"
      decimals="0"
      id="ixv-4872"
      unitRef="uref_782852322">388</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_856585502"
      decimals="0"
      id="ixv-4873"
      unitRef="uref_782852322">-5513338</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1744689869"
      decimals="0"
      id="ixv-4874"
      unitRef="uref_782852322">-5512906</us-gaap:StockholdersEquity>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_922302944"
      decimals="0"
      id="ixv-4875"
      unitRef="uref_782852322">1379187</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_2073882789"
      decimals="0"
      id="ixv-4876"
      unitRef="uref_782852322">1379187</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:NetIncomeLoss
      contextRef="cref_922302944"
      decimals="0"
      id="ixv-4877"
      unitRef="uref_782852322">1222873</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_2073882789"
      decimals="0"
      id="ixv-4878"
      unitRef="uref_782852322">1222873</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="cref_1420044896"
      decimals="0"
      id="ixv-4879"
      unitRef="uref_1643728509">443470</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_1420044896"
      decimals="0"
      id="ixv-4880"
      unitRef="uref_782852322">44</us-gaap:StockholdersEquity>
    <us-gaap:SharesOutstanding
      contextRef="cref_1922201456"
      decimals="0"
      id="ixv-4881"
      unitRef="uref_1643728509">3877118</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_1922201456"
      decimals="0"
      id="ixv-4882"
      unitRef="uref_782852322">388</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_697399911"
      decimals="0"
      id="ixv-4883"
      unitRef="uref_782852322">-5669652</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_590850699"
      decimals="0"
      id="ixv-4884"
      unitRef="uref_782852322">-5669220</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_912874889"
      decimals="0"
      id="fc_2058414422"
      unitRef="uref_1643728509">3877118</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_912874889"
      decimals="0"
      id="fc_912874889"
      unitRef="uref_782852322">388</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1632373075"
      decimals="0"
      id="fc_1632373075"
      unitRef="uref_782852322">24612</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_1165240187"
      decimals="0"
      id="fc_871821477"
      unitRef="uref_782852322">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1076052647"
      decimals="0"
      id="ixv-4889"
      unitRef="uref_782852322">-30298</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1165240187"
      decimals="0"
      id="ixv-4890"
      unitRef="uref_782852322">-30298</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="cref_766315599"
      decimals="0"
      id="ixv-4891"
      unitRef="uref_1643728509">3877118</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="cref_766315599"
      decimals="0"
      id="ixv-4892"
      unitRef="uref_782852322">388</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_662933581"
      decimals="0"
      id="ixv-4893"
      unitRef="uref_782852322">24612</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_1990009149"
      decimals="0"
      id="ixv-4894"
      unitRef="uref_782852322">-30298</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="cref_650794531"
      decimals="0"
      id="ixv-4895"
      unitRef="uref_782852322">-5298</us-gaap:StockholdersEquity>
    <figxu:SharesSubjectToForfeiture
      contextRef="cref_686673142"
      decimals="0"
      id="ixv-4897"
      unitRef="uref_1643728509">491250</figxu:SharesSubjectToForfeiture>
    <figxu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_193269061"
      decimals="0"
      id="ixv-4898"
      unitRef="uref_1643728509">15065000</figxu:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1953066301"
      decimals="2"
      id="ixv-4899"
      unitRef="uref_1624330424">10</us-gaap:SharesIssuedPricePerShare>
    <figxu:NumberOfSharesNoLongerSubjectToForfeitures
      contextRef="cref_1229833713"
      decimals="0"
      id="ixv-4900"
      unitRef="uref_1643728509">491250</figxu:NumberOfSharesNoLongerSubjectToForfeitures>
    <us-gaap:NetIncomeLoss
      contextRef="cref_2073882789"
      decimals="0"
      id="ixv-4901"
      unitRef="uref_782852322">1222873</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="cref_1165240187"
      decimals="0"
      id="ixv-4902"
      unitRef="uref_782852322">-30298</us-gaap:NetIncomeLoss>
    <us-gaap:CostsAndExpensesRelatedParty
      contextRef="cref_1165240187"
      decimals="0"
      id="ixv-4903"
      unitRef="uref_782852322">18840</us-gaap:CostsAndExpensesRelatedParty>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_2073882789"
      decimals="0"
      id="ixv-4904"
      unitRef="uref_782852322">1379187</us-gaap:InvestmentIncomeInterest>
    <us-gaap:IncreaseDecreaseInPrepaidExpense
      contextRef="cref_2073882789"
      decimals="0"
      id="ixv-4905"
      unitRef="uref_782852322">-18960</us-gaap:IncreaseDecreaseInPrepaidExpense>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="cref_2073882789"
      decimals="0"
      id="ixv-4906"
      unitRef="uref_782852322">87995</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="cref_1165240187"
      decimals="0"
      id="ixv-4907"
      unitRef="uref_782852322">11458</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInDueToRelatedParties
      contextRef="cref_2073882789"
      decimals="0"
      id="ixv-4908"
      unitRef="uref_782852322">2316</us-gaap:IncreaseDecreaseInDueToRelatedParties>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="cref_2073882789"
      decimals="0"
      id="ixv-4909"
      unitRef="uref_782852322">-47043</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
      contextRef="cref_2073882789"
      decimals="0"
      id="ixv-4910"
      unitRef="uref_782852322">-47043</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_1744689869"
      decimals="0"
      id="ixv-4911"
      unitRef="uref_782852322">905141</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="cref_590850699"
      decimals="0"
      id="ixv-4912"
      unitRef="uref_782852322">858098</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <figxu:OfferingCostsIncludedInAccruedOfferingCosts
      contextRef="cref_1165240187"
      decimals="0"
      id="ixv-4913"
      unitRef="uref_782852322">21577</figxu:OfferingCostsIncludedInAccruedOfferingCosts>
    <figxu:OfferingCostsPaidThroughPromissoryNoteRelatedParty
      contextRef="cref_1165240187"
      decimals="0"
      id="ixv-4914"
      unitRef="uref_782852322">25000</figxu:OfferingCostsPaidThroughPromissoryNoteRelatedParty>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="cref_2073882789" id="ixv-2171">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Note 1 &#x2014; Description of Organization and Business Operations&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; FIGX Capital Acquisition Corp. (the &#x201c;Company&#x201d;) is a blank check company incorporated as a Cayman Islands exempted company on February&#160;20, 2025. The Company was incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the &#x201c;Business Combination&#x201d;). The Company has not selected any specific Business Combination target. While the Company may pursue an initial Business Combination target in any industry, the Company is concentrating its efforts in identifying businesses in the financial and business services industry, with a focus on differentiated financial services and financial services-adjacent platforms. The Company is an early-stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early-stage and emerging growth companies. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; As of March 31, 2026, the Company had not commenced any operations. All activity for the period from February&#160;20, 2025 (inception) through March 31, 2026 relates to the Company&#x2019;s formation, the Initial Public Offering (as defined below) and subsequent to the Initial Public Offering, identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering. The Company has selected December&#160;31 as its fiscal year end. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company&#x2019;s sponsor is FIGX Acquisition Partners LLC (the &#x201c;Sponsor&#x201d;).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Registration Statement on Form S-1 for the Initial Public Offering, initially filed with the U.S. Securities and Exchange Commission (the &#x201c;SEC&#x201d;) on May 21, 2025, as amended (File No. 333-287453), was declared effective on June 26, 2025 (the &#x201c;IPO Registration Statement&#x201d;). On June 30, 2025, the Company consummated the initial public offering of 15,065,000 units of the Company (the &#x201c;Public Units&#x201d;) at $10.00 per Public Unit, which includes the full exercise of the Over-Allotment Option (as defined in Note 6) of 1,965,000 units of the Company (the &#x201c;Option Units&#x201d;) at $10.00 per Option Unit, generating gross proceeds of $150,650,000 (the &#x201c;Initial Public Offering&#x201d;), as discussed in Note 3. Simultaneously with the closing of the Initial Public Offering, the Company consummated the sale of an aggregate of 443,470 private placement units (the &#x201c;Private Placement Units&#x201d; and together with the Public Units, the &#x201c;Units&#x201d;) to the Sponsor and Cantor Fitzgerald &amp;amp; Co. (&#x201c;Cantor&#x201d;), the representative of the several underwriters of the Initial Public Offering (the &#x201c;Underwriters&#x201d;), at a price of $10.00 per Private Placement Unit in a private placement, generating gross proceeds of $4,434,700 (the &#x201c;Private Placement&#x201d;), as discussed in Note 4. Of those 443,470 Private Placement Units, the Sponsor purchased 312,470 Private Placement Units and Cantor purchased 131,000 Private Placement Units. Each Public Unit consists of one Class A ordinary share par value $0.0001 per share, of the Company (the &#x201c;Class A Ordinary Shares&#x201d; and with respect to the Class A Ordinary Shares included in the Public Units, the &#x201c;Public Shares&#x201d;) and one-half of one redeemable warrant of the Company (each, a &#x201c;Public Warrant&#x201d;), with each whole Public Warrant entitling the holder thereof to purchase one Class A Ordinary Share for $11.50 per share. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; Transaction costs amounted to $9,575,365, consisting of $2,620,000 cash underwriting fee, the Deferred Underwriting Fee (as defined in Note 6) of $6,419,000, and $536,365 of other offering costs. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Business Combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the net balance in the Trust Account (as defined below) (excluding the amount of the Deferred Underwriting Fee held and income taxes payable on the income earned on the Trust Account, if any) at the time of the signing an agreement to enter into a Business Combination. However, the Company will only complete a Business Combination if the post-Business Combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act&#160;of&#160;1940, as amended (the &#x201c;Investment Company Act&#x201d;). There is no assurance that the Company will be able to successfully effect a Business Combination. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; Upon the closing of the Initial Public Offering on June 30, 2025, an amount of $150,650,000 ($10.00 per Unit) from the net proceeds of the Initial Public Offering, and a portion of the proceeds of the Private Placement, are held in a trust account (the &#x201c;Trust Account&#x201d;) located in the United&#160;States with Continental Stock Transfer&#160;&amp;amp; Trust Company (&#x201c;Continental&#x201d;) acting as trustee. The Trust Account funds are initially invested only in U.S.&#160;government treasury obligations with a maturity of 185&#160;days or less or in money market funds meeting certain conditions under Rule&#160;2a-7 under the Investment Company Act, which invest only in direct U.S.&#160;government treasury obligations. The holding of these assets in this form is intended to be temporary and for the sole purpose of facilitating the intended Business Combination. To mitigate the risk that the Company might be deemed to be an investment company for purposes of the Investment Company Act, which risk increases the longer that the Company holds investments in the Trust Account, the Company may, at any time (based on the Company&#x2019;s management&#x2019;s (&#x201c;Management&#x201d;) ongoing assessment of all factors related to the potential status under the Investment Company Act), instruct Continental to liquidate the investments held in the Trust Account and instead to hold the funds in the Trust Account in cash or in an interest bearing demand deposit account at a bank. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its taxes, if any, the proceeds from the Initial Public Offering and the Private Placement&#160;will not be released from the Trust Account until the earliest of (i)&#160;the completion of the initial Business Combination, (ii)&#160;the redemption of the Public Shares if the Company is unable to complete the initial Business Combination by June 30, 2027, 24&#160;months from the closing of the Initial Public Offering or by such earlier liquidation date as the Company&#x2019;s board of directors may approve (the &#x201c;Combination Period&#x201d;), subject to applicable law, or (iii)&#160;the redemption of the Public Shares properly submitted in connection with a shareholder vote to amend the Company&#x2019;s amended and restated memorandum and articles of association (the &#x201c;Amended and Restated Articles&#x201d;) to modify the (1) substance or timing of the Company&#x2019;s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Public Shares if the Company has not consummated an initial Business Combination within the Combination Period or (2) any other material provisions relating to shareholders&#x2019; rights or pre-initial Business Combination activity. The proceeds deposited in the Trust Account could become subject to the claims of the Company&#x2019;s creditors, if any, which could have priority over the claims of the holders of the Public Shares (the &#x201c;Public Shareholders&#x201d;). &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Company will provide the Public Shareholders with the opportunity to redeem all or a portion of their Public Shares upon the completion of the initial Business Combination either (i)&#160;in connection with a general meeting called to approve the initial Business Combination or (ii)&#160;without a shareholder vote by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed initial Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Shareholders will be entitled to redeem their Public Shares at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account calculated as of two&#160;business&#160;days prior to the consummation of the initial Business Combination, including interest earned on the funds held in the Trust Account (less taxes payable, if any), divided by the number of then outstanding Public Shares, subject to the limitations. The amount in the Trust Account was $10.29 per Public Share as of March 31, 2026. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Ordinary Shares (as defined in Note 5) subject to redemption are recorded at a redemption value and classified as temporary equity upon the completion of the Initial Public Offering, in accordance with Financial Accounting Standards Board (&#x201c;FASB&#x201d;) Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic&#160;480, &#x201c;Distinguishing Liabilities from Equity.&#x201d;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Company has only the duration of the Combination Period to complete the initial Business Combination. However, if the Company is unable to complete its initial Business Combination within the Combination Period, the Company will as promptly as reasonably possible, but not more than ten&#160;business&#160;days thereafter, redeem the Public Shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest earned on the funds held in the Trust Account (less taxes payable, if any, and up to $100,000 of interest income to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will constitute full and complete payment for the Public Shares and completely extinguish Public Shareholders&#x2019; rights as shareholders (including the right to receive further liquidation or other distributions, if any), subject to the Company&#x2019;s obligations under Cayman Islands law to provide for claims of creditors and subject to the other requirements of applicable law. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Sponsor, officers and directors have entered into a letter agreement with the Company, dated June 26, 2025 (the &#x201c;Letter Agreement&#x201d;), pursuant to which they have agreed to (i)&#160;waive their redemption rights with respect to their Founder Shares (as defined in Note 5), Private Placement Shares (as defined in Note 4) and Public Shares in connection with (x) the completion of the initial Business Combination or an earlier redemption in connection with the commencement of the procedures to consummate the initial Business Combination if the Company determines it is desirable to facilitate the completion of the initial Business Combination and (y) a shareholder vote to approve an amendment to the Amended and Restated Articles to modify (1) the substance or timing of the Company&#x2019;s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Public Shares if the Company has not consummated an initial Business Combination within the Combination Period or (2) any other material provisions relating to shareholders&#x2019; rights or pre-initial Business Combination activity; (ii)&#160;waive their redemption rights with respect to their Founder Shares and public shares in connection with a shareholder vote to approve an amendment to the Company&#x2019;s amended and restated memorandum and articles of association; (iii)&#160;waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares and Private Placement Shares if the Company fails to complete the initial Business Combination within the Combination Period, although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination within the Combination Period and to liquidating distributions from assets outside the Trust Account; and (iv)&#160;vote any Founder Shares and Private Placement Shares held by them and any Public Shares purchased during or after the Initial Public Offering (including in open market and privately negotiated transactions) in favor of the initial Business Combination. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or other similar agreement or Business Combination agreement, reduce the amount of funds in the Trust Account to below the lesser of (i)&#160;$10.00 per Public Share and (ii)&#160;the actual amount per Public Share held in the Trust Account as of the date of the liquidation of the Trust Account, if less than $10.00 per Public Share due to reductions in the value of the Trust Account assets, less income taxes payable, if any, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the Trust Account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company&#x2019;s indemnity of the Underwriters against certain liabilities, including liabilities under the Securities Act&#160;of&#160;1933, as amended (the &#x201c;Securities Act&#x201d;). However, the Company has not asked the Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether the Sponsor has sufficient funds to satisfy its indemnity obligations and the Company believes that the Sponsor&#x2019;s only assets are securities of the Company. Therefore, the Company cannot assure that the Sponsor would be able to satisfy those obligations. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Commencing on August 18, 2025, the holders of Public Units may elect to separately trade the Public Shares and the Public Warrants included in the Public Units. No fractional Public Warrants will be issued upon separation of the Public Units and only whole Public Warrants trade on the Global Market tier of The Nasdaq Stock Market LLC under the symbols &#x201c;FIGX&#x201d; and &#x201c;FIGXW,&#x201d; respectively. Holders of Public Units need to have their brokers contact Continental, the Company&#x2019;s transfer agent, in order to separate the Public Units into Public Shares and Public Warrants.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Liquidity and Capital Resources&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; At March 31, 2026, the Company had $858,098 in cash and working capital of $732,822. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company&#x2019;s officers and directors may, but are not obligated to, loan the Company funds as may be required (&#x201c;Working Capital Loans&#x201d;). If the Company completes a Business Combination, the Company may repay any Working Capital Loans at that time. Up to $1,500,000 of such Working Capital Loans may be converted into units of the post-Business Combination entity at a price of $10.00 per unit. The units (and underlying securities) would be identical to the Private Placement Units (and underlying securities). As of March 31, 2026, the Company had &lt;span style="-sec-ix-hidden:fc_577268480"&gt;no&lt;/span&gt; borrowings under the Working Capital Loans. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In connection with the Company&#x2019;s assessment of going concern considerations in accordance with the FASB ASC Topic 205-40, &#x201c;Presentation of Financial Statements-Going Concern,&#x201d; the Company does not believe it will need to raise additional funds in order to meet the expenditures required for operating its business. However, if the estimate of the costs of identifying a target business, undertaking in-depth due diligence and negotiating a Business Combination are less than the actual amount necessary to do so, the Company may have insufficient funds available to operate its business prior to the initial Business Combination. Management has determined that upon consummation of the Initial Public Offering and the Private Placement, the Company has sufficient funds to finance the working capital needs of the Company within one year from the date of issuance of the accompanying unaudited condensed financial statements.&lt;/p&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <dei:EntityIncorporationDateOfIncorporation contextRef="cref_2073882789" id="ixv-4915">2025-02-20</dei:EntityIncorporationDateOfIncorporation>
    <figxu:YearOfInception contextRef="cref_2073882789" id="ixv-4916">February&#160;20, 2025 (inception) through March 31, 2026</figxu:YearOfInception>
    <figxu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_193269061"
      decimals="0"
      id="ixv-4917"
      unitRef="uref_1643728509">15065000</figxu:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1953066301"
      decimals="2"
      id="ixv-4918"
      unitRef="uref_1624330424">10</us-gaap:SharesIssuedPricePerShare>
    <figxu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_876891952"
      decimals="0"
      id="ixv-4919"
      unitRef="uref_1643728509">1965000</figxu:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1194647520"
      decimals="2"
      id="ixv-4920"
      unitRef="uref_1624330424">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_193269061"
      decimals="0"
      id="ixv-4921"
      unitRef="uref_782852322">150650000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <figxu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1265031843"
      decimals="0"
      id="ixv-4922"
      unitRef="uref_1643728509">443470</figxu:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1577398097"
      decimals="2"
      id="ixv-4923"
      unitRef="uref_1624330424">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfPrivatePlacement
      contextRef="cref_87242767"
      decimals="0"
      id="ixv-4924"
      unitRef="uref_782852322">4434700</us-gaap:ProceedsFromIssuanceOfPrivatePlacement>
    <figxu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1265031843"
      decimals="0"
      id="ixv-4925"
      unitRef="uref_1643728509">443470</figxu:UnitsIssuedDuringPeriodSharesNewIssues>
    <figxu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_87242767"
      decimals="0"
      id="ixv-4926"
      unitRef="uref_1643728509">312470</figxu:UnitsIssuedDuringPeriodSharesNewIssues>
    <figxu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1656677855"
      decimals="0"
      id="ixv-4927"
      unitRef="uref_1643728509">131000</figxu:UnitsIssuedDuringPeriodSharesNewIssues>
    <figxu:NumberOfSharesIssued
      contextRef="cref_658539131"
      decimals="0"
      id="ixv-4928"
      unitRef="uref_1643728509">1</figxu:NumberOfSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_2023810708"
      decimals="4"
      id="ixv-4929"
      unitRef="uref_1624330424">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="cref_2094522727"
      decimals="0"
      id="ixv-4930"
      unitRef="uref_1643728509">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_2094522727"
      decimals="2"
      id="ixv-4931"
      unitRef="uref_1624330424">11.5</us-gaap:CommonStockParOrStatedValuePerShare>
    <figxu:TransactionCosts
      contextRef="cref_2073882789"
      decimals="0"
      id="ixv-4932"
      unitRef="uref_782852322">9575365</figxu:TransactionCosts>
    <figxu:CashUnderwritingFee
      contextRef="cref_2073882789"
      decimals="0"
      id="ixv-4933"
      unitRef="uref_782852322">2620000</figxu:CashUnderwritingFee>
    <figxu:DeferredUnderwritingFee
      contextRef="cref_590850699"
      decimals="0"
      id="ixv-4934"
      unitRef="uref_782852322">6419000</figxu:DeferredUnderwritingFee>
    <us-gaap:OtherDeferredCostsNet
      contextRef="cref_590850699"
      decimals="0"
      id="ixv-4935"
      unitRef="uref_782852322">536365</us-gaap:OtherDeferredCostsNet>
    <figxu:FairMarketValuePercentage
      contextRef="cref_2073882789"
      decimals="2"
      id="ixv-4936"
      unitRef="uref_1980527220">0.80</figxu:FairMarketValuePercentage>
    <us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired
      contextRef="cref_416625089"
      decimals="2"
      id="ixv-4937"
      unitRef="uref_1980527220">0.50</us-gaap:BusinessAcquisitionPercentageOfVotingInterestsAcquired>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_655433440"
      decimals="0"
      id="ixv-4938"
      unitRef="uref_782852322">150650000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_868657012"
      decimals="2"
      id="ixv-4939"
      unitRef="uref_1624330424">10</us-gaap:SaleOfStockPricePerShare>
    <figxu:NumberOfMaturityDays contextRef="cref_1718174532" id="ixv-4940">P185D</figxu:NumberOfMaturityDays>
    <figxu:PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination
      contextRef="cref_590850699"
      decimals="2"
      id="ixv-4941"
      unitRef="uref_1980527220">1</figxu:PercentageOfPublicSharesToBeRedeemedOnNonCompletionOfBusinessCombination>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_90591216"
      decimals="2"
      id="ixv-4942"
      unitRef="uref_1624330424">10.29</us-gaap:SharesIssuedPricePerShare>
    <figxu:InterestToPayDissolutionExpenses
      contextRef="cref_2073882789"
      decimals="0"
      id="ixv-4943"
      unitRef="uref_782852322">100000</figxu:InterestToPayDissolutionExpenses>
    <figxu:RedemptionPercentage
      contextRef="cref_2073882789"
      decimals="2"
      id="ixv-4944"
      unitRef="uref_1980527220">1</figxu:RedemptionPercentage>
    <us-gaap:SharePrice
      contextRef="cref_89960868"
      decimals="2"
      id="ixv-4945"
      unitRef="uref_1624330424">10</us-gaap:SharePrice>
    <us-gaap:SharePrice
      contextRef="cref_90591216"
      decimals="2"
      id="ixv-4946"
      unitRef="uref_1624330424">10</us-gaap:SharePrice>
    <us-gaap:Cash
      contextRef="cref_590850699"
      decimals="0"
      id="fc_130530284"
      unitRef="uref_782852322">858098</us-gaap:Cash>
    <figxu:WorkingCapitalSurplus
      contextRef="cref_590850699"
      decimals="0"
      id="ixv-4948"
      unitRef="uref_782852322">732822</figxu:WorkingCapitalSurplus>
    <figxu:WorkingCapitalLoans
      contextRef="cref_1776448153"
      decimals="0"
      id="ixv-4949"
      unitRef="uref_782852322">1500000</figxu:WorkingCapitalLoans>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_479841610"
      decimals="2"
      id="ixv-4950"
      unitRef="uref_1624330424">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:SignificantAccountingPoliciesTextBlock contextRef="cref_2073882789" id="ixv-2255">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Note 2 &#x2014; Significant Accounting Policies&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Basis of Presentation&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of Management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying unaudited condensed financial statements should be read in conjunction with the Company&#x2019;s Annual Report on Form 10-K for the period ended December 31, 2025, as filed with the SEC on March 9, 2026. The interim results for the three months ended March 31, 2026, and for the period from February 20, 2025 (inception) through March 31, 2025 are not necessarily indicative of the results to be expected for the year ending December 31, 2026 or for any future periods.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Emerging Growth Company Status&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups Act&#160;of&#160;2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act of 2002, as amended, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Further, Section&#160;102(b)(1)&#160;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies, but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 19.8pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The preparation of the accompanying unaudited condensed financial statements in conformity with GAAP requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the accompanying unaudited condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Making estimates requires Management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the accompanying unaudited condensed financial statements, which Management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Investments Held in Trust Account&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; As of March 31, 2026 and December 31, 2025, the assets held in the Trust Account, amounting to $155,087,314 and $153,708,127, respectively, were held in money market funds investing in U.S. government treasury bills. The Company accounts for its investments held in the Trust Account as trading securities under FASB ASC Topic 320, &#x201c;Investments&#x2014;Debt and Equity Securities,&#x201d; where securities are presented at fair value in the accompanying condensed balance sheets. Unrealized gains and losses resulting from the change in fair value of investments held in the Trust Account are recorded as interest earned on investments held in the Trust Account in the accompanying unaudited condensed statements of operations. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#x2019;s financial condition, results of operations, and cash flows. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Offering Costs&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company complies with the requirements of the FASB ASC Topic 340-10-S99, &#x201c;Accounting for Offering Costs&#x201d;, and SEC Staff Accounting Bulletin 5A,&#160;&#x201c;Expenses of Offering.&#x201d; Deferred offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC Topic 470-20, &#x201c;Debt with Conversion and Other Options,&#x201d; addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Public Units between Public Shares and Public Warrants, prorate, allocating the Initial Public Offering proceeds to the assigned value of the Public Warrants and to the Public Shares. Offering costs allocated to the Public Shares were charged to temporary equity and offering costs allocated to the Public Warrants and Private Placement Warrants (as defined in Note 4) were charged to shareholders&#x2019; deficit. After Management&#x2019;s evaluation, the Public Warrants and the Private Placement Warrants were accounted for under equity treatment.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under FASB ASC Topic&#160;820, &#x201c;Fair Value Measurements and Disclosures,&#x201d; approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for income taxes under FASB ASC Topic&#160;740, &#x201c;Income Taxes&#x201d; (&#x201c;ASC 740&#x201d;), which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. Management determined that the Cayman Islands is the Company&#x2019;s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of March 31, 2026 and December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_1747469282"&gt;no&lt;/span&gt; unrecognized tax benefits and &lt;span style="-sec-ix-hidden:fc_332762307"&gt;no&lt;/span&gt; amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United&#160;States. As such, the Company&#x2019;s tax provision was zero for the periods presented.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Class A Ordinary Shares Subject to Possible Redemption&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Public Shares contain a redemption feature that allows for the redemption of such Public Shares in connection with the Company&#x2019;s liquidation, if there is a Public Shareholder vote to modify (1) the substance or timing of the Company&#x2019;s obligation to allow redemption in connection with a Business Combination or to redeem 100% of the Public Shares if the Company does not complete an initial Business Combination within the Combination Period or (2) any other material provisions relating to Public Shareholders&#x2019; rights or pre-initial Business Combination activity, or if there is a shareholder vote or tender offer in connection with the initial Business Combination. In accordance with FASB ASC Topic 480-10-S99, &#x201c;Distinguishing Liabilities from Equity&#x201d;, the Company classifies Class A Ordinary Shares subject to possible redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of March 31, 2026 and December 31, 2025, Class A Ordinary Shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#x2019; deficit section of the accompanying condensed balance sheets. As of March 31, 2026 and December 31, 2025, the Class A Ordinary Shares subject to possible redemption reflected in the accompanying condensed balance sheets are reconciled in the following table: &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 88%; text-align: left"&gt;Gross proceeds&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;150,650,000&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td&gt;Less:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="text-align: left"&gt;Proceeds allocated to Public Warrants&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(1,438,708&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left"&gt;Redeemable Class A Ordinary Shares issuance cost&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(9,468,729&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="padding-bottom: 1.5pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;13,965,565&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="text-align: left"&gt;Class A Ordinary Shares subject to possible redemption, December 31, 2025&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;153,708,128&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-bottom: 1.5pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,379,187&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Class A Ordinary Shares subject to possible redemption, March 31, 2026&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;155,087,315&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Net Income (Loss) per Ordinary Share&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share.&#x201d; The Company has two classes of Ordinary Shares, the Class A Ordinary Shares and Class B Ordinary Shares (as defined in Note 5). Income and losses are shared pro rata between the two classes of Ordinary Shares. Net income (loss) per Ordinary Share is computed by dividing net income (loss) by the weighted average number of Ordinary Shares outstanding for the period.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The calculation of diluted income (loss) per Ordinary Share does not consider the effect of the Warrants issued in connection with the (i) Initial Public Offering, and (ii) Private Placement, since their exercise is contingent upon future events. As a result, diluted net income (loss) per Ordinary Share is the same as basic income (loss) per Ordinary Share. The redemption feature for the Ordinary Shares equals fair value, and therefore does not create a different class of Ordinary Shares or require an adjustment to the earnings per-share calculation. The redemption at fair value does not represent an economic benefit to the holders that is different from what is received by other stockholders, because the shares could be sold on the open market. Accretion associated with the redeemable shares of Class A Ordinary Shares is excluded from earnings per share as the redemption value approximates the fair value.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table reflects the calculation of basic and diluted net income (loss) per Ordinary Share:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Three Months Ended&lt;br/&gt;  March     31, 2026&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Period from&lt;br/&gt;  February 20,     2025 (Inception) &lt;br/&gt; Through March 31, 2025&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;A&lt;br/&gt;  redeemable&lt;br/&gt;  and non-&lt;br/&gt; redeemable&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;B&lt;br/&gt;  non-&lt;br/&gt; redeemable&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;A&lt;br/&gt;  redeemable&lt;br/&gt;  and non-&lt;br/&gt; redeemable&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;B&lt;br/&gt;  non-&lt;br/&gt; redeemable&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;Basic net income (loss) per Ordinary Share&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-left: 0.25in; width: 52%; text-align: left"&gt;Allocation of net income (loss)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;978,299&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;244,574&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden:fc_29103227"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;(30,298&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="padding-left: 0.125in"&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-left: 0.25in"&gt;Basic weighted average Ordinary Shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;15,508,470&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,877,118&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden:fc_1382390127"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,385,868&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left"&gt;Basic net income (loss) per Ordinary Share&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;0.06&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;0.06&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden:fc_1734056557"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;(0.01&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Three Months Ended &lt;br/&gt; March     31, 2026&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Period &lt;br/&gt; February 20, 2025     (Inception)&lt;br/&gt;  Through March 31, 2025&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;A&lt;br/&gt;  redeemable&lt;br/&gt;  and non-&lt;br/&gt; redeemable&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;B&lt;br/&gt;  non-&lt;br/&gt; redeemable&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;A &lt;br/&gt; redeemable&lt;br/&gt;  and non-&lt;br/&gt; redeemable&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;B&lt;br/&gt;  non-&lt;br/&gt; redeemable&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;Diluted net income (loss) per Ordinary Share&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-left: 0.25in; width: 52%; text-align: left"&gt;Allocation of net income (loss)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;978,298&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;244,574&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden:fc_560032873"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;(30,298&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="padding-left: 0.125in"&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-left: 0.25in"&gt;Diluted weighted average Ordinary Shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;15,508,470&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,877,118&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden:fc_386513161"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,385,868&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left"&gt;Diluted net income (loss) per Ordinary Share&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;0.06&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;0.06&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden:fc_555863419"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;(0.01&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Warrant Instruments&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Company accounts for the Warrants issued in connection with the Initial Public Offering and the Private Placement in accordance with the guidance contained in FASB ASC Topic 815, &#x201c;Derivatives and Hedging&#x201d;. Accordingly, the Company evaluated and classified the Warrant instruments under equity treatment at their assigned value. There are 7,532,500 Public Warrants and 221,735 Private Placement Warrants outstanding as of March 31, 2026 and December 31, 2025. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Share-Based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company records share-based compensation in accordance with FASB ASC Topic 718, &#x201c;Compensation-Share Compensation&#x201d; (&#x201c;ASC 718&#x201d;), guidance to account for its share-based compensation. It defines a fair value-based method of accounting for an employee share option or similar equity instrument. The Company recognizes all forms of share-based payments at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest. Share-based payments are valued by multiplying the marketable value per Founder Share by the probability of successful closing of an initial Business Combination. Grants of share-based payment awards issued to non-employees for services rendered have been recorded at the fair value of the share-based payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. Share-based compensation expenses are included in costs and operating expenses depending on the nature of the services provided in the accompanying unaudited condensed statement of operations.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In November&#160;2023, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;) Topic 2023-07, &#x201c;Segment Reporting (Topic&#160;280): Improvements to Reportable Segment Disclosures&#x201d; (&#x201c;ASU 2023-07&#x201d;). The amendments in ASU 2023-07 require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to a company&#x2019;s chief operating decision maker (&#x201c;CODM&#x201d;), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. ASU 2023-07 requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s)&#160;of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities are required to provide all annual disclosures currently required by FASB ASC Topic 280, &#x201c;Segment Reporting&#x201d; (&#x201c;ASC 280&#x201d;), in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in ASU 2023-07 and existing segment disclosures in ASC 280. ASU 2023-07 is effective for fiscal&#160;years beginning after December&#160;15, 2023, and interim periods within fiscal&#160;years beginning after December&#160;15, 2024, with early adoption permitted. The Company adopted ASU 2023-07 on February&#160;20, 2025, its inception date.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the accompanying unaudited condensed financial statements.&lt;/p&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock contextRef="cref_2073882789" id="ixv-2260">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Basis of Presentation&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;) for interim financial information and in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of Management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accompanying unaudited condensed financial statements should be read in conjunction with the Company&#x2019;s Annual Report on Form 10-K for the period ended December 31, 2025, as filed with the SEC on March 9, 2026. The interim results for the three months ended March 31, 2026, and for the period from February 20, 2025 (inception) through March 31, 2025 are not necessarily indicative of the results to be expected for the year ending December 31, 2026 or for any future periods.&lt;/p&gt;</us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock>
    <figxu:EmergingGrowthCompanyStatusPolicyTextBlock contextRef="cref_2073882789" id="ixv-2270">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Emerging Growth Company Status&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company is an &#x201c;emerging growth company,&#x201d; as defined in Section&#160;2(a)&#160;of the Securities Act, as modified by the Jumpstart Our Business Startups Act&#160;of&#160;2012 (the &#x201c;JOBS Act&#x201d;), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act of 2002, as amended, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Further, Section&#160;102(b)(1)&#160;of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies, but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company&#x2019;s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.&lt;/p&gt;</figxu:EmergingGrowthCompanyStatusPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="cref_2073882789" id="ixv-2278">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Use of Estimates&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The preparation of the accompanying unaudited condensed financial statements in conformity with GAAP requires Management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the accompanying unaudited condensed financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 16.2pt"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Making estimates requires Management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the accompanying unaudited condensed financial statements, which Management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:InvestmentPolicyTextBlock contextRef="cref_2073882789" id="ixv-2300">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Investments Held in Trust Account&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; As of March 31, 2026 and December 31, 2025, the assets held in the Trust Account, amounting to $155,087,314 and $153,708,127, respectively, were held in money market funds investing in U.S. government treasury bills. The Company accounts for its investments held in the Trust Account as trading securities under FASB ASC Topic 320, &#x201c;Investments&#x2014;Debt and Equity Securities,&#x201d; where securities are presented at fair value in the accompanying condensed balance sheets. Unrealized gains and losses resulting from the change in fair value of investments held in the Trust Account are recorded as interest earned on investments held in the Trust Account in the accompanying unaudited condensed statements of operations. &lt;/p&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_590850699"
      decimals="0"
      id="ixv-4951"
      unitRef="uref_782852322">155087314</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_1744689869"
      decimals="0"
      id="ixv-4952"
      unitRef="uref_782852322">153708127</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="cref_2073882789" id="ixv-2306">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Deposit Insurance Corporation coverage limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company&#x2019;s financial condition, results of operations, and cash flows. &lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:FederalDepositInsuranceCorporationPremiumExpense
      contextRef="cref_2073882789"
      decimals="0"
      id="ixv-4953"
      unitRef="uref_782852322">250000</us-gaap:FederalDepositInsuranceCorporationPremiumExpense>
    <figxu:OfferingCostsPolicyTextBlock contextRef="cref_2073882789" id="ixv-2312">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Offering Costs&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company complies with the requirements of the FASB ASC Topic 340-10-S99, &#x201c;Accounting for Offering Costs&#x201d;, and SEC Staff Accounting Bulletin 5A,&#160;&#x201c;Expenses of Offering.&#x201d; Deferred offering costs consist principally of professional and registration fees that are related to the Initial Public Offering. FASB ASC Topic 470-20, &#x201c;Debt with Conversion and Other Options,&#x201d; addresses the allocation of proceeds from the issuance of convertible debt into its equity and debt components. The Company applies this guidance to allocate Initial Public Offering proceeds from the Public Units between Public Shares and Public Warrants, prorate, allocating the Initial Public Offering proceeds to the assigned value of the Public Warrants and to the Public Shares. Offering costs allocated to the Public Shares were charged to temporary equity and offering costs allocated to the Public Warrants and Private Placement Warrants (as defined in Note 4) were charged to shareholders&#x2019; deficit. After Management&#x2019;s evaluation, the Public Warrants and the Private Placement Warrants were accounted for under equity treatment.&lt;/p&gt;</figxu:OfferingCostsPolicyTextBlock>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy contextRef="cref_2073882789" id="ixv-2319">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Fair Value of Financial Instruments&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The fair value of the Company&#x2019;s assets and liabilities, which qualify as financial instruments under FASB ASC Topic&#160;820, &#x201c;Fair Value Measurements and Disclosures,&#x201d; approximates the carrying amounts represented in the accompanying condensed balance sheets, primarily due to their short-term nature.&lt;/p&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="cref_2073882789" id="ixv-2325">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Income Taxes&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company accounts for income taxes under FASB ASC Topic&#160;740, &#x201c;Income Taxes&#x201d; (&#x201c;ASC 740&#x201d;), which requires an asset and liability approach to financial accounting and reporting for income taxes. Deferred income tax assets and liabilities are computed for differences between the financial statement and tax bases of assets and liabilities that will result in future taxable or deductible amounts, based on enacted tax laws and rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. Management determined that the Cayman Islands is the Company&#x2019;s major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of March 31, 2026 and December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_1747469282"&gt;no&lt;/span&gt; unrecognized tax benefits and &lt;span style="-sec-ix-hidden:fc_332762307"&gt;no&lt;/span&gt; amounts accrued for interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company is considered to be an exempted Cayman Islands company with no connection to any other taxable jurisdiction and is presently not subject to income taxes or income tax filing requirements in the Cayman Islands or the United&#160;States. As such, the Company&#x2019;s tax provision was zero for the periods presented.&lt;/p&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock contextRef="cref_2073882789" id="ixv-2352">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Class A Ordinary Shares Subject to Possible Redemption&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Public Shares contain a redemption feature that allows for the redemption of such Public Shares in connection with the Company&#x2019;s liquidation, if there is a Public Shareholder vote to modify (1) the substance or timing of the Company&#x2019;s obligation to allow redemption in connection with a Business Combination or to redeem 100% of the Public Shares if the Company does not complete an initial Business Combination within the Combination Period or (2) any other material provisions relating to Public Shareholders&#x2019; rights or pre-initial Business Combination activity, or if there is a shareholder vote or tender offer in connection with the initial Business Combination. In accordance with FASB ASC Topic 480-10-S99, &#x201c;Distinguishing Liabilities from Equity&#x201d;, the Company classifies Class A Ordinary Shares subject to possible redemption outside of permanent equity as the redemption provisions are not solely within the control of the Company. The Company recognizes changes in redemption value immediately as they occur and will adjust the carrying value of redeemable shares to equal the redemption value at the end of each reporting period. Immediately upon the closing of the Initial Public Offering, the Company recognized the accretion from initial book value to redemption value. The change in the carrying value of redeemable shares will result in charges against additional paid-in capital (to the extent available) and accumulated deficit. Accordingly, as of March 31, 2026 and December 31, 2025, Class A Ordinary Shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders&#x2019; deficit section of the accompanying condensed balance sheets. As of March 31, 2026 and December 31, 2025, the Class A Ordinary Shares subject to possible redemption reflected in the accompanying condensed balance sheets are reconciled in the following table: &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 88%; text-align: left"&gt;Gross proceeds&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;150,650,000&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td&gt;Less:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="text-align: left"&gt;Proceeds allocated to Public Warrants&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(1,438,708&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left"&gt;Redeemable Class A Ordinary Shares issuance cost&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(9,468,729&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="padding-bottom: 1.5pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;13,965,565&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="text-align: left"&gt;Class A Ordinary Shares subject to possible redemption, December 31, 2025&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;153,708,128&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-bottom: 1.5pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,379,187&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Class A Ordinary Shares subject to possible redemption, March 31, 2026&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;155,087,315&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock>
    <figxu:PercentageOfPublicShares
      contextRef="cref_2073882789"
      decimals="2"
      id="ixv-4954"
      unitRef="uref_1980527220">1</figxu:PercentageOfPublicShares>
    <us-gaap:TemporaryEquityTableTextBlock contextRef="cref_2073882789" id="ixv-4955">As of March 31, 2026 and December 31, 2025, the Class A Ordinary Shares subject to possible redemption reflected in the accompanying condensed balance sheets are reconciled in the following table:&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 88%; text-align: left"&gt;Gross proceeds&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;150,650,000&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td&gt;Less:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="text-align: left"&gt;Proceeds allocated to Public Warrants&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(1,438,708&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left"&gt;Redeemable Class A Ordinary Shares issuance cost&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;(9,468,729&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="padding-bottom: 1.5pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;13,965,565&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="text-align: left"&gt;Class A Ordinary Shares subject to possible redemption, December 31, 2025&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;153,708,128&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td&gt;Plus:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-bottom: 1.5pt"&gt;Accretion of carrying value to redemption value&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;1,379,187&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left; padding-bottom: 2.5pt"&gt;Class A Ordinary Shares subject to possible redemption, March 31, 2026&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt"&gt;&#160;&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;$&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: right"&gt;155,087,315&lt;/td&gt; &lt;td style="padding-bottom: 2.5pt; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:TemporaryEquityTableTextBlock>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="cref_1702843046"
      decimals="0"
      id="ixv-4956"
      unitRef="uref_782852322">150650000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:ProceedsFromIssuanceOfWarrants
      contextRef="cref_1702843046"
      decimals="0"
      id="ixv-4957"
      unitRef="uref_782852322">1438708</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease
      contextRef="cref_1702843046"
      decimals="0"
      id="ixv-4958"
      unitRef="uref_782852322">9468729</us-gaap:TemporaryEquityIssuePeriodIncreaseOrDecrease>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_1702843046"
      decimals="0"
      id="ixv-4959"
      unitRef="uref_782852322">13965565</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_1744689869"
      decimals="0"
      id="ixv-4960"
      unitRef="uref_782852322">153708128</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityAccretionToRedemptionValue
      contextRef="cref_2073882789"
      decimals="0"
      id="ixv-4961"
      unitRef="uref_782852322">1379187</us-gaap:TemporaryEquityAccretionToRedemptionValue>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="cref_590850699"
      decimals="0"
      id="ixv-4962"
      unitRef="uref_782852322">155087315</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="cref_2073882789" id="ixv-2423">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Net Income (Loss) per Ordinary Share&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, &#x201c;Earnings Per Share.&#x201d; The Company has two classes of Ordinary Shares, the Class A Ordinary Shares and Class B Ordinary Shares (as defined in Note 5). Income and losses are shared pro rata between the two classes of Ordinary Shares. Net income (loss) per Ordinary Share is computed by dividing net income (loss) by the weighted average number of Ordinary Shares outstanding for the period.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The calculation of diluted income (loss) per Ordinary Share does not consider the effect of the Warrants issued in connection with the (i) Initial Public Offering, and (ii) Private Placement, since their exercise is contingent upon future events. As a result, diluted net income (loss) per Ordinary Share is the same as basic income (loss) per Ordinary Share. The redemption feature for the Ordinary Shares equals fair value, and therefore does not create a different class of Ordinary Shares or require an adjustment to the earnings per-share calculation. The redemption at fair value does not represent an economic benefit to the holders that is different from what is received by other stockholders, because the shares could be sold on the open market. Accretion associated with the redeemable shares of Class A Ordinary Shares is excluded from earnings per share as the redemption value approximates the fair value.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table reflects the calculation of basic and diluted net income (loss) per Ordinary Share:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Three Months Ended&lt;br/&gt;  March     31, 2026&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Period from&lt;br/&gt;  February 20,     2025 (Inception) &lt;br/&gt; Through March 31, 2025&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;A&lt;br/&gt;  redeemable&lt;br/&gt;  and non-&lt;br/&gt; redeemable&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;B&lt;br/&gt;  non-&lt;br/&gt; redeemable&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;A&lt;br/&gt;  redeemable&lt;br/&gt;  and non-&lt;br/&gt; redeemable&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;B&lt;br/&gt;  non-&lt;br/&gt; redeemable&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;Basic net income (loss) per Ordinary Share&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-left: 0.25in; width: 52%; text-align: left"&gt;Allocation of net income (loss)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;978,299&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;244,574&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden:fc_29103227"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;(30,298&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="padding-left: 0.125in"&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-left: 0.25in"&gt;Basic weighted average Ordinary Shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;15,508,470&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,877,118&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden:fc_1382390127"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,385,868&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left"&gt;Basic net income (loss) per Ordinary Share&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;0.06&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;0.06&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden:fc_1734056557"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;(0.01&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Three Months Ended &lt;br/&gt; March     31, 2026&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Period &lt;br/&gt; February 20, 2025     (Inception)&lt;br/&gt;  Through March 31, 2025&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;A&lt;br/&gt;  redeemable&lt;br/&gt;  and non-&lt;br/&gt; redeemable&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;B&lt;br/&gt;  non-&lt;br/&gt; redeemable&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;A &lt;br/&gt; redeemable&lt;br/&gt;  and non-&lt;br/&gt; redeemable&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;B&lt;br/&gt;  non-&lt;br/&gt; redeemable&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;Diluted net income (loss) per Ordinary Share&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-left: 0.25in; width: 52%; text-align: left"&gt;Allocation of net income (loss)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;978,298&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;244,574&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden:fc_560032873"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;(30,298&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="padding-left: 0.125in"&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-left: 0.25in"&gt;Diluted weighted average Ordinary Shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;15,508,470&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,877,118&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden:fc_386513161"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,385,868&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left"&gt;Diluted net income (loss) per Ordinary Share&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;0.06&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;0.06&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden:fc_555863419"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;(0.01&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="cref_2073882789" id="ixv-2446">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The following table reflects the calculation of basic and diluted net income (loss) per Ordinary Share:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Three Months Ended&lt;br/&gt;  March     31, 2026&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Period from&lt;br/&gt;  February 20,     2025 (Inception) &lt;br/&gt; Through March 31, 2025&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;A&lt;br/&gt;  redeemable&lt;br/&gt;  and non-&lt;br/&gt; redeemable&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;B&lt;br/&gt;  non-&lt;br/&gt; redeemable&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;A&lt;br/&gt;  redeemable&lt;br/&gt;  and non-&lt;br/&gt; redeemable&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;B&lt;br/&gt;  non-&lt;br/&gt; redeemable&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;Basic net income (loss) per Ordinary Share&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-left: 0.25in; width: 52%; text-align: left"&gt;Allocation of net income (loss)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;978,299&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;244,574&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden:fc_29103227"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;(30,298&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="padding-left: 0.125in"&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-left: 0.25in"&gt;Basic weighted average Ordinary Shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;15,508,470&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,877,118&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden:fc_1382390127"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,385,868&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left"&gt;Basic net income (loss) per Ordinary Share&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;0.06&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;0.06&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden:fc_1734056557"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;(0.01&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Three Months Ended &lt;br/&gt; March     31, 2026&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the Period &lt;br/&gt; February 20, 2025     (Inception)&lt;br/&gt;  Through March 31, 2025&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;A&lt;br/&gt;  redeemable&lt;br/&gt;  and non-&lt;br/&gt; redeemable&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;B&lt;br/&gt;  non-&lt;br/&gt; redeemable&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;A &lt;br/&gt; redeemable&lt;br/&gt;  and non-&lt;br/&gt; redeemable&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;Class&#160;B&lt;br/&gt;  non-&lt;br/&gt; redeemable&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;Diluted net income (loss) per Ordinary Share&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;Numerator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-left: 0.25in; width: 52%; text-align: left"&gt;Allocation of net income (loss)&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;978,298&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;244,574&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden:fc_560032873"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;(30,298&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="padding-left: 0.125in"&gt;Denominator:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="padding-left: 0.25in"&gt;Diluted weighted average Ordinary Shares outstanding&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;15,508,470&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,877,118&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden:fc_386513161"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="border-bottom: Black 1.5pt solid; text-align: right"&gt;3,385,868&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left"&gt;Diluted net income (loss) per Ordinary Share&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;0.06&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;0.06&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden:fc_555863419"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;(0.01&lt;/td&gt; &lt;td style="text-align: left"&gt;)&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_352539731"
      decimals="0"
      id="ixv-4963"
      unitRef="uref_782852322">978299</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_716079242"
      decimals="0"
      id="ixv-4964"
      unitRef="uref_782852322">244574</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="cref_1385100879"
      decimals="0"
      id="ixv-4965"
      unitRef="uref_782852322">-30298</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_352539731"
      decimals="0"
      id="ixv-4966"
      unitRef="uref_1643728509">15508470</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_716079242"
      decimals="0"
      id="ixv-4967"
      unitRef="uref_1643728509">3877118</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="cref_1385100879"
      decimals="0"
      id="ixv-4968"
      unitRef="uref_1643728509">3385868</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_352539731"
      decimals="2"
      id="ixv-4969"
      unitRef="uref_1624330424">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_716079242"
      decimals="2"
      id="ixv-4970"
      unitRef="uref_1624330424">0.06</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="cref_1385100879"
      decimals="2"
      id="ixv-4971"
      unitRef="uref_1624330424">-0.01</us-gaap:EarningsPerShareBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="cref_352539731"
      decimals="0"
      id="ixv-4972"
      unitRef="uref_782852322">978298</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="cref_716079242"
      decimals="0"
      id="ixv-4973"
      unitRef="uref_782852322">244574</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="cref_1385100879"
      decimals="0"
      id="ixv-4974"
      unitRef="uref_782852322">-30298</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_352539731"
      decimals="0"
      id="ixv-4975"
      unitRef="uref_1643728509">15508470</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_716079242"
      decimals="0"
      id="ixv-4976"
      unitRef="uref_1643728509">3877118</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="cref_1385100879"
      decimals="0"
      id="ixv-4977"
      unitRef="uref_1643728509">3385868</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_352539731"
      decimals="2"
      id="ixv-4978"
      unitRef="uref_1624330424">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_716079242"
      decimals="2"
      id="ixv-4979"
      unitRef="uref_1624330424">0.06</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="cref_1385100879"
      decimals="2"
      id="ixv-4980"
      unitRef="uref_1624330424">-0.01</us-gaap:EarningsPerShareDiluted>
    <figxu:WarrantInstrumentsPolicyTextBlock contextRef="cref_2073882789" id="ixv-2738">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Warrant Instruments&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Company accounts for the Warrants issued in connection with the Initial Public Offering and the Private Placement in accordance with the guidance contained in FASB ASC Topic 815, &#x201c;Derivatives and Hedging&#x201d;. Accordingly, the Company evaluated and classified the Warrant instruments under equity treatment at their assigned value. There are 7,532,500 Public Warrants and 221,735 Private Placement Warrants outstanding as of March 31, 2026 and December 31, 2025. &lt;/p&gt;</figxu:WarrantInstrumentsPolicyTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_2045073809"
      decimals="0"
      id="ixv-4981"
      unitRef="uref_1643728509">7532500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_2044206887"
      decimals="0"
      id="ixv-4982"
      unitRef="uref_1643728509">221735</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="cref_2073882789" id="ixv-2745">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Share-Based Compensation&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company records share-based compensation in accordance with FASB ASC Topic 718, &#x201c;Compensation-Share Compensation&#x201d; (&#x201c;ASC 718&#x201d;), guidance to account for its share-based compensation. It defines a fair value-based method of accounting for an employee share option or similar equity instrument. The Company recognizes all forms of share-based payments at their fair value on the grant date, which are based on the estimated number of awards that are ultimately expected to vest. Share-based payments are valued by multiplying the marketable value per Founder Share by the probability of successful closing of an initial Business Combination. Grants of share-based payment awards issued to non-employees for services rendered have been recorded at the fair value of the share-based payment, which is the more readily determinable value. The grants are amortized on a straight-line basis over the requisite service periods, which is generally the vesting period. If an award is granted, but vesting does not occur, any previously recognized compensation cost is reversed in the period related to the termination of service. Share-based compensation expenses are included in costs and operating expenses depending on the nature of the services provided in the accompanying unaudited condensed statement of operations.&lt;/p&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="cref_2073882789" id="ixv-2767">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;In November&#160;2023, the FASB issued Accounting Standards Update (&#x201c;ASU&#x201d;) Topic 2023-07, &#x201c;Segment Reporting (Topic&#160;280): Improvements to Reportable Segment Disclosures&#x201d; (&#x201c;ASU 2023-07&#x201d;). The amendments in ASU 2023-07 require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to a company&#x2019;s chief operating decision maker (&#x201c;CODM&#x201d;), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. ASU 2023-07 requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s)&#160;of segment profit or loss in assessing segment performance and deciding how to allocate resources. Public entities are required to provide all annual disclosures currently required by FASB ASC Topic 280, &#x201c;Segment Reporting&#x201d; (&#x201c;ASC 280&#x201d;), in interim periods, and entities with a single reportable segment are required to provide all the disclosures required by the amendments in ASU 2023-07 and existing segment disclosures in ASC 280. ASU 2023-07 is effective for fiscal&#160;years beginning after December&#160;15, 2023, and interim periods within fiscal&#160;years beginning after December&#160;15, 2024, with early adoption permitted. The Company adopted ASU 2023-07 on February&#160;20, 2025, its inception date.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Management does not believe that any other recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the accompanying unaudited condensed financial statements.&lt;/p&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <figxu:InitialPublicOfferingTextBlock contextRef="cref_2073882789" id="fc_348863750">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;3 &#x2014;&#160;Initial Public Offering&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; Pursuant to the Initial Public Offering on June 30, 2025, the Company sold 15,065,000 Public Units at a purchase price of $10.00 per Public Unit for a total of $150,650,000, which includes the full exercise of the Over-Allotment Option in the amount of 1,965,000 Option Units. Each Public Unit consists of one Public Share, and one-half of one Public Warrant. Each whole Public Warrant entitles the holder to purchase one Class&#160;A Ordinary Share at a price of $11.50 per share, subject to adjustment. Each Public Warrant will become exercisable 30&#160;days after the completion of the initial Business Combination and will expire five&#160;years after the completion of the initial Business Combination, or earlier upon redemption or liquidation. &lt;/p&gt;</figxu:InitialPublicOfferingTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="cref_193269061"
      decimals="0"
      id="ixv-4983"
      unitRef="uref_1643728509">15065000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_1953066301"
      decimals="2"
      id="ixv-4984"
      unitRef="uref_1624330424">10</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="cref_1229833713"
      decimals="0"
      id="ixv-4985"
      unitRef="uref_782852322">150650000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="cref_193269061"
      decimals="0"
      id="ixv-4986"
      unitRef="uref_782852322">1965000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:SaleOfStockDescriptionOfTransaction contextRef="cref_1624330424" id="ixv-4987">Each Public Unit consists of one Public Share, and one-half of one Public Warrant</us-gaap:SaleOfStockDescriptionOfTransaction>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="cref_602195142"
      decimals="0"
      id="ixv-4988"
      unitRef="uref_1643728509">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_2094522727"
      decimals="2"
      id="ixv-4989"
      unitRef="uref_1624330424">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <figxu:WarrantExercisableTerm contextRef="cref_137234818" id="ixv-4990">P30D</figxu:WarrantExercisableTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="cref_346691114" id="ixv-4991">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <figxu:PrivatePlacementTextBlock contextRef="cref_2073882789" id="ixv-2783">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;4&#160;&#x2014;&#160;Private Placement&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; Simultaneously with the closing of the Initial Public Offering, the Sponsor and Cantor purchased an aggregate of 443,470 Private Placement Units&#160;at a price of $10.00 per Private Placement Unit in the Private Placement. Each Private Placement Unit consists of one Class A Ordinary Share (as included in the Private Placement Units, the &#x201c;Private Placement Shares&#x201d;) and one-half of one warrant (each, a &#x201c;Private Placement Warrant&#x201d; and together with the Public Warrants, the &#x201c;Warrants&#x201d;). Each Private Placement Warrant entitles the holder to purchase one Class&#160;A Ordinary Share at a price of $11.50 per shares, subject to adjustments. Each Private Placement Warrant will become exercisable 30&#160;days after the completion of the initial Business Combination and will not expire except upon liquidation. If the initial Business Combination is not completed within the Combination Period, the net proceeds from the Private Placement&#160;held in the Trust Account will be used to fund the redemption of the Public Shares (subject to the requirements of applicable law). &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Private Placement Warrants contained in the Private Placement Units&#160;are identical to the Public Warrants except, the Private Placement Warrants (i)&#160;may not (including the Class&#160;A Ordinary Shares issuable upon exercise of these Private Placement Warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30&#160;days after the completion of the initial Business Combination, (ii)&#160;will be entitled to registration rights and (iii)&#160;with respect to Private Placement Warrants held by Cantor and/or its designees, will not be exercisable more than five&#160;years from the commencement of sales in the Initial Public Offering in accordance with Financial Industry Regulatory Authority Rule&#160;5110(g)(8).&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Sponsor and the Company&#x2019;s officers and directors have entered into the Letter Agreement, pursuant to which they have agreed to (i)&#160;waive their redemption rights with respect to their Founder Shares, Private Placement Shares and Public Shares in connection with (x) the completion of the initial Business Combination or an earlier redemption in connection with the commencement of the procedures to consummate the initial Business Combination if the Company determines it is desirable to facilitate the completion of the initial Business Combination and (y) a shareholder vote to approve an amendment to the Amended and Restated Articles to (1) modify the substance or timing of the Company&#x2019;s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Public Shares if the Company has not consummated an initial Business Combination within the Combination Period or (2) any other material provisions relating to shareholders&#x2019; rights or pre-initial Business Combination activity; (ii)&#160;waive their redemption rights with respect to their Founder Shares and public shares in connection with a shareholder vote to approve an amendment to the Company&#x2019;s amended and restated memorandum and articles of association; (iii)&#160;waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares and Private Placement Shares if the Company fails to complete the initial Business Combination within the Combination Period, although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination within the Combination Period and to liquidating distributions from assets outside the Trust Account; and (iv)&#160;vote any Founder Shares and Private Placement Shares held by them and any Public Shares purchased during or after the Initial Public Offering (including in open market and privately negotiated transactions) in favor of the initial Business Combination. &lt;/p&gt;</figxu:PrivatePlacementTextBlock>
    <figxu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_1062453623"
      decimals="0"
      id="ixv-4992"
      unitRef="uref_1643728509">443470</figxu:UnitsIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_479841610"
      decimals="2"
      id="ixv-4993"
      unitRef="uref_1624330424">10</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="cref_1794589647"
      decimals="0"
      id="ixv-4994"
      unitRef="uref_1643728509">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_1794589647"
      decimals="2"
      id="ixv-4995"
      unitRef="uref_1624330424">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <figxu:WarrantExercisableTerm contextRef="cref_993633427" id="ixv-4996">P30D</figxu:WarrantExercisableTerm>
    <figxu:PercentageOfPublicShares
      contextRef="cref_2073882789"
      decimals="2"
      id="ixv-4997"
      unitRef="uref_1980527220">1</figxu:PercentageOfPublicShares>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock contextRef="cref_2073882789" id="ixv-2810">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;5&#160;&#x2014;&#160;Related Party Transactions&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Founder Shares&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; On February&#160;27, 2025, the Sponsor made a capital contribution of $25,000, or approximately $0.006 per share, through payments of offering costs and expenses on the Company&#x2019;s behalf, for which the Company issued 3,877,118 of the Company&#x2019;s Class&#160;B ordinary shares, par value $0.0001 per share (the &#x201c;Class B Ordinary Shares&#x201d;, and together with the Class A Ordinary Shares, the &#x201c;Ordinary Shares&#x201d;), to the Sponsor (such shares, the &#x201c;Founder Shares&#x201d;). Up to 491,250 of the Founder Shares were to be surrendered by the Sponsor for no consideration depending on the extent to which the Over-Allotment Option was exercised. On June 30, 2025, the Underwriters exercised the Over-Allotment Option in full as part of the closing of the Initial Public Offering. As such, those 491,250 Founder Shares are no longer subject to forfeiture. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; In May 2025, the Sponsor sold membership interests equivalent to a total of 260,000 Founder Shares to the Company&#x2019;s independent directors and Management, for a consideration of $0.006 per share, or an aggregate total amount of $1,664. The transfer of the Founder Shares to the Company&#x2019;s independent directors and Management are in the scope of ASC 718. Under ASC 718, share-based compensation associated with equity-classified awards is measured at fair value upon the assignment date. The fair value of the 260,000 Founder Shares granted to the Company&#x2019;s independent directors and Management on their respective grant dates in May 2025 had an aggregate total of $384,020, or $1.477 per Founder Share. The transfer of membership interests agreement stated that the recipient must be providing services at the date of the Initial Public Offering for 50% of their membership interest to become vested and non-forfeitable, thus, $164,499 was recorded as compensation expense upon consummation of the Initial Public Offering on June 30, 2025. The remaining 50% of their membership interests are contingent upon continued services through consummation of the initial Business Combination, which will be recognized at the date a Business Combination is probable (i.e., upon consummation of a Business Combination) in the amount of $166,162. As of March 31, 2026, the Company determined that the initial Business Combination is not considered probable and therefore the remaining compensation expense has not been recognized. The fair value of the Founder Shares was derived through a third-party valuation in which the implied Class A Ordinary Share price of $9.85 was multiplied by the market adjustment of 15%. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Founder Shares are designated as Class&#160;B Ordinary Shares and, except as described below, are identical to the Class&#160;A Ordinary Shares, and holders of Founder Shares have the same shareholder rights as Public Shareholders, except that (i)&#160;the Founder Shares are subject to certain transfer restrictions, as described in more detail below; (ii)&#160;the Founder Shares are entitled to registration rights; (iii)&#160;pursuant to the Letter Agreement, the Sponsor and the Company&#x2019;s officers and directors have agreed to (1)&#160;waive their redemption rights with respect to their Founder Shares, Private Placement Shares and Public Shares in connection with the completion of the initial Business Combination, (2)&#160;waive their redemption rights with respect to their Founder Shares, Private Placement Shares and Public Shares in connection with a shareholder vote to approve an amendment to the Amended and Restated Articles to modify (x) the substance or timing of the Company&#x2019;s obligation to allow redemption in connection with its initial Business Combination or to redeem 100% of the Public Shares if the Company has not consummated an initial Business Combination within the Combination Period or (y) any other material provisions relating to shareholders&#x2019; rights or pre-initial Business Combination activity, (3)&#160;waive their rights to liquidating distributions from the Trust Account with respect to their Founder Shares or Private Placement Shares if the Company fails to complete the initial Business Combination within the Combination Period, although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares they hold if the Company fails to complete the initial Business Combination within such time period and to liquidating distributions from assets outside the Trust Account and (4) vote any Founder Shares and Private Placement Shares held by them and any Public Shares purchased during or after the Initial Public Offering (including in open market and privately-negotiated transactions, aside from Ordinary Shares they may purchase in compliance with the requirements of Rule&#160;14e-5 under the Exchange&#160;Act, which would not be voted in favor of approving the Business Combination transaction) in favor of the initial Business Combination; (iv)&#160;the Founder Shares are automatically convertible into Class&#160;A Ordinary Shares in connection with the consummation of the initial Business Combination or earlier at the option of the holder on a one-for-one basis, subject to adjustment as described herein and in the Amended and Restated Articles; and (v)&#160;prior to the closing of the initial Business Combination, only holders of the Class&#160;B Ordinary Shares will be entitled to vote on the appointment and removal of directors or continuing the Company in a jurisdiction outside the Cayman Islands (including any Special Resolution (as defined in Note 7) required to amend the Amended and Restated Articles or to adopt new constitutional documents, in each case, as a result of the Company approving a transfer by way of continuation in a jurisdiction outside the Cayman Islands).&#160; &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;IPO Promissory Note&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Sponsor agreed to loan the Company an aggregate of up to $300,000 to be used for a portion of the expenses of the Initial Public Offering pursuant to an unsecured promissory note (the &#x201c;IPO Promissory Note&#x201d;). The loan was non-interest bearing, unsecured and due at the earlier of December&#160;31, 2025, or the closing of the Initial Public Offering. The Company borrowed $164,210 under the terms of the IPO Promissory Note, which amount was repaid from the proceeds of Initial Public Offering and Private Placement. Borrowings under the IPO Promissory Note are no longer available. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Administrative Services Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Company entered into the Administrative Services Agreement, dated June 26, 2025, with the Sponsor, pursuant to which, commencing on June 27, 2025, the Company pays an aggregate of $10,000 per month to the Sponsor for office space, utilities, and secretarial and administrative support. These monthly fees will cease upon the completion of the initial Business Combination or the liquidation of the Company. For the three months ended March 31, 2026 and for the period from February 20, 2025 (inception) through March 31, 2025, the Company incurred $30,000 and $&lt;span style="-sec-ix-hidden:fc_1900016742"&gt;0&lt;/span&gt; in fees for these services, respectively. As of March 31, 2026 and December 31, 2025, the Company owed the Sponsor $4,259 and $1,943, respectively, related to these services, which is included in the &#x201c;Due to related party&#x201d; line item of the accompanying condensed balance sheet. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Consultant Services Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Chief Financial Officer provides accounting services to the Company at a monthly rate of $3,000, which commenced on September 1, 2025, pursuant to a consulting agreement, dated September 10, 2025 by and between the Company and the Chief Financial Officer. For the three months ended March 31, 2026 and for the period from February 20, 2025 (inception) through March 31, 2025, the Company incurred $9,000 and $&lt;span style="-sec-ix-hidden:fc_1904871896"&gt;0&lt;/span&gt; in fees for these services, respectively. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Working Capital Loans&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company&#x2019;s officers and directors may, but are not obligated to, loan the Company Working Capital Loans as may be required. If the Company completes a Business Combination, the Company would repay the Working Capital Loans. In the event that a Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans, but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into private placement equivalent units of the post-Business Combination entity at a price of $10.00 per unit at the option of the lender. As of March 31, 2026 and December 31, 2025, no such Working Capital Loans were outstanding. &lt;/p&gt;</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="cref_341322038"
      decimals="0"
      id="ixv-4998"
      unitRef="uref_782852322">25000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_973616570"
      decimals="3"
      id="ixv-4999"
      unitRef="uref_1624330424">0.006</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_973616570"
      decimals="0"
      id="ixv-5000"
      unitRef="uref_1643728509">3877118</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_973616570"
      decimals="4"
      id="ixv-5001"
      unitRef="uref_1624330424">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="cref_842610705"
      decimals="0"
      id="ixv-5002"
      unitRef="uref_1643728509">491250</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
      contextRef="cref_2026176110"
      decimals="0"
      id="ixv-5003"
      unitRef="uref_1643728509">491250</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensationForfeited>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="cref_1976653253"
      decimals="0"
      id="ixv-5004"
      unitRef="uref_1643728509">260000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="cref_326555146"
      decimals="3"
      id="ixv-5005"
      unitRef="uref_1624330424">0.006</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="cref_1976653253"
      decimals="0"
      id="ixv-5006"
      unitRef="uref_782852322">1664</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="cref_1976653253"
      decimals="0"
      id="ixv-5007"
      unitRef="uref_1643728509">260000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross
      contextRef="cref_1243115437"
      decimals="0"
      id="ixv-5008"
      unitRef="uref_782852322">384020</us-gaap:StockGrantedDuringPeriodValueSharebasedCompensationGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="cref_1243115437"
      decimals="3"
      id="ixv-5009"
      unitRef="uref_1624330424">1.477</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <figxu:MembershipInterestPercentage
      contextRef="cref_1243115437"
      decimals="2"
      id="ixv-5010"
      unitRef="uref_1980527220">0.50</figxu:MembershipInterestPercentage>
    <us-gaap:ShareBasedCompensation
      contextRef="cref_1588645818"
      decimals="0"
      id="ixv-5011"
      unitRef="uref_782852322">164499</us-gaap:ShareBasedCompensation>
    <figxu:MembershipInterestPercentage
      contextRef="cref_1243115437"
      decimals="2"
      id="ixv-5012"
      unitRef="uref_1980527220">0.50</figxu:MembershipInterestPercentage>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1
      contextRef="cref_1172863110"
      decimals="0"
      id="ixv-5013"
      unitRef="uref_782852322">166162</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_1121590045"
      decimals="2"
      id="ixv-5014"
      unitRef="uref_1624330424">9.85</us-gaap:SharesIssuedPricePerShare>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="cref_1243115437"
      decimals="2"
      id="ixv-5015"
      unitRef="uref_1980527220">0.15</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <figxu:BusinessCombinationRedemptionPercentage
      contextRef="cref_2073882789"
      decimals="2"
      id="ixv-5016"
      unitRef="uref_1980527220">1</figxu:BusinessCombinationRedemptionPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="cref_284125506"
      decimals="0"
      id="ixv-5017"
      unitRef="uref_782852322">300000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:NotesPayable
      contextRef="cref_1782949702"
      decimals="0"
      id="ixv-5018"
      unitRef="uref_782852322">164210</us-gaap:NotesPayable>
    <us-gaap:AdministrativeFeesExpense
      contextRef="cref_1120564630"
      decimals="0"
      id="ixv-5019"
      unitRef="uref_782852322">10000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:AdministrativeFeesExpense
      contextRef="cref_2073882789"
      decimals="0"
      id="ixv-5020"
      unitRef="uref_782852322">30000</us-gaap:AdministrativeFeesExpense>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="cref_34845724"
      decimals="0"
      id="fc_34845724"
      unitRef="uref_782852322">4259</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="cref_89425586"
      decimals="0"
      id="fc_89425586"
      unitRef="uref_782852322">1943</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="cref_214983395"
      decimals="0"
      id="ixv-5023"
      unitRef="uref_782852322">3000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <us-gaap:RelatedPartyTransactionAmountsOfTransaction
      contextRef="cref_2073882789"
      decimals="0"
      id="ixv-5024"
      unitRef="uref_782852322">9000</us-gaap:RelatedPartyTransactionAmountsOfTransaction>
    <figxu:WorkingCapitalLoans
      contextRef="cref_1062453623"
      decimals="0"
      id="ixv-5025"
      unitRef="uref_782852322">1500000</figxu:WorkingCapitalLoans>
    <us-gaap:SharesIssuedPricePerShare
      contextRef="cref_391051224"
      decimals="2"
      id="ixv-5026"
      unitRef="uref_1624330424">10</us-gaap:SharesIssuedPricePerShare>
    <figxu:WorkingCapitalLoans
      contextRef="cref_2073882789"
      decimals="0"
      id="ixv-5027"
      unitRef="uref_782852322">0</figxu:WorkingCapitalLoans>
    <figxu:WorkingCapitalLoans
      contextRef="cref_1702843046"
      decimals="0"
      id="ixv-5028"
      unitRef="uref_782852322">0</figxu:WorkingCapitalLoans>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock contextRef="cref_2073882789" id="ixv-2870">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;6&#160;&#x2014;&#160;Commitments and Contingencies&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"&gt;&lt;span style="font-weight: bold;"&gt;Risks and Uncertainties&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Registration Rights&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The holders of (i) Founder Shares, (ii) Private Placement Units&#160;(and their underlying securities) and units&#160;that may be issued upon conversion of any Working Capital Loans (and their underlying securities), if any, (iii) any Class&#160;A Ordinary Shares issuable upon conversion of the Founder Shares and any Class&#160;A Ordinary Shares held at the completion of the Initial Public Offering by the holders of the Founder Shares prior to the Initial Public Offering, have registration rights to require the Company to register a sale of any of the Company&#x2019;s securities held by them and any other securities of the Company acquired by them prior to the consummation of the initial Business Combination pursuant to a registration rights agreement, dated June 26, 2025, by and among the Company and certain holders thereto. These holders are entitled to make up to three demands excluding short form demands, and have piggyback registration rights. Cantor may only make a demand on one occasion and only during the five-year period beginning on the effective date of the Initial Public Offering. In addition, Cantor may participate in a piggyback registration only during the seven-year period beginning on the effective date of the Initial Public Offering. The Company will bear the expenses incurred in connection with the filing of any such registration statements.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Underwriting Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Underwriters had a 45-day option from the date of the Initial Public Offering to purchase up to an additional 1,965,000&#160;Option Units to cover over-allotments, if any (the &#x201c;Over-Allotment Option&#x201d;). On June 30, 2025, the Underwriters fully exercised their Over-Allotment Option. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Underwriters were entitled to a cash underwriting discount of $2,620,000 (2.0% of the gross proceeds of the Public Units offered in the Initial Public Offering, whether or not the Over-Allotment Option was exercised), which was paid to the Underwriters upon the closing of the Initial Public Offering. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; Additionally, the Underwriters are entitled to a deferred underwriting fee of (i) 4.0% of the gross proceeds of the Initial Public Offering held in the Trust Account (other than those sold pursuant to the Over-Allotment Option) and (ii) 6.0% of the gross proceeds sold pursuant to the Over-Allotment Option, which equates to $6,419,000 in the aggregate following the full exercise of the Over-Allotment Option and is payable to the Underwriters upon the completion of the initial Business Combination, subject to the terms of the underwriting agreement, dated June 26, 2025 (such discount, the &#x201c;Deferred Underwriting Fee&#x201d;). &lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <figxu:UnderwritersOverallotmentOptionPeriod contextRef="cref_2073882789" id="ixv-5029">P45D</figxu:UnderwritersOverallotmentOptionPeriod>
    <figxu:UnitsIssuedDuringPeriodSharesNewIssues
      contextRef="cref_874436487"
      decimals="0"
      id="ixv-5030"
      unitRef="uref_1643728509">1965000</figxu:UnitsIssuedDuringPeriodSharesNewIssues>
    <figxu:CashUnderwritingDiscount
      contextRef="cref_2073882789"
      decimals="0"
      id="ixv-5031"
      unitRef="uref_782852322">2620000</figxu:CashUnderwritingDiscount>
    <figxu:ProceedsFromIssuanceInitialPublicOfferingPercentage
      contextRef="cref_2073882789"
      decimals="3"
      id="ixv-5032"
      unitRef="uref_1980527220">-0.02</figxu:ProceedsFromIssuanceInitialPublicOfferingPercentage>
    <figxu:ProceedsFromIssuanceInitialPublicOfferingPercentage
      contextRef="cref_1940954079"
      decimals="3"
      id="ixv-5033"
      unitRef="uref_1980527220">0.04</figxu:ProceedsFromIssuanceInitialPublicOfferingPercentage>
    <figxu:ProceedsFromIssuanceInitialPublicOfferingPercentage
      contextRef="cref_874436487"
      decimals="3"
      id="ixv-5034"
      unitRef="uref_1980527220">0.06</figxu:ProceedsFromIssuanceInitialPublicOfferingPercentage>
    <figxu:DeferredUnderwritingFee
      contextRef="cref_423467157"
      decimals="0"
      id="ixv-5035"
      unitRef="uref_782852322">6419000</figxu:DeferredUnderwritingFee>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock contextRef="cref_2073882789" id="fc_1078712991">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;7&#160;&#x2014;&#160;Shareholders&#x2019; Deficit&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Preference Shares&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Company is authorized to issue a total of 1,000,000 preference shares at par value of $0.0001 each. As of March 31, 2026 and December 31, 2025, there were &lt;span style="-sec-ix-hidden:fc_972610273"&gt;&lt;span style="-sec-ix-hidden:fc_927666548"&gt;no&lt;/span&gt;&lt;/span&gt; preference shares issued or outstanding. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Class&#160;A Ordinary Shares&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Company is authorized to issue a total of 200,000,000 Class&#160;A Ordinary Shares at par value of $0.0001 each. As of March 31, 2026 and December 31, 2025, there were 443,470 Class&#160;A Ordinary Shares issued and outstanding, excluding 15,065,000 Class A Ordinary Shares subject to possible redemption. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Class&#160;B Ordinary Shares&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Company is authorized to issue a total of 20,000,000 Class&#160;B Ordinary Shares at par value of $0.0001 each. As of March 31, 2026 and December 31, 2025, there were 3,877,118 Class B Ordinary Shares issued and outstanding. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Founder Shares will automatically convert into Class&#160;A Ordinary Shares in connection with the consummation of the initial Business Combination or earlier at the option of the holder on a one-for-one basis, subject to adjustment for share subdivisions, share capitalizations, reorganizations, recapitalizations and the like. In the case that additional Class&#160;A Ordinary Shares, or any other equity-linked securities, are issued or deemed issued in excess of the amounts sold in the Initial Public Offering and related to or in connection with the closing of the initial Business Combination, the ratio at which Class&#160;B Ordinary Shares convert into Class&#160;A Ordinary Shares will be adjusted (unless the holders of a majority of the outstanding Class&#160;B Ordinary Shares agree to waive such adjustment with respect to any such issuance or deemed issuance) so that the number of Class&#160;A Ordinary Shares issuable upon conversion of all Class&#160;B Ordinary Shares will equal, in the aggregate, 20.5% of the sum of (i)&#160;the total number of all Class&#160;A Ordinary Shares outstanding upon the completion of the Initial Public Offering (including any Class&#160;A Ordinary Shares issued pursuant to the Over-Allotment Option and excluding the Private Placement&#160;Shares&#160;and the Class&#160;A Ordinary Shares underlying the Private Placement Warrants), plus (ii)&#160;all Class&#160;A Ordinary Shares and equity-linked securities issued or deemed issued, in connection with the closing of the initial Business Combination (excluding any shares or equity-linked securities issued, or to be issued, to any seller in the initial Business Combination and any private placement-equivalent units issued to the Sponsor or any of its affiliates or to the Company&#x2019;s officers or directors upon conversion of any Working Capital Loans) minus (iii)&#160;any redemptions of Public Shares by Public Shareholders in connection with an initial Business Combination; provided that such conversion of Founder Shares will never occur on a less than one-for-one basis. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; Except as set forth below, holders of the Ordinary Shares are entitled to one vote for each share held on all matters to be voted on by shareholders. Unless specified in the Amended and Restated Articles or as required by the Companies Act (As Revised) of the Cayman Islands or stock exchange rules, an ordinary resolution under Cayman Islands law and the Amended and Restated Articles, which requires the affirmative vote of at least a majority of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the Company is generally required to approve any matter voted on by the Company&#x2019;s shareholders. Approval of certain actions requires a special resolution under Cayman Islands law, which (except as specified below) requires the affirmative vote of at least two-thirds of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting (a &#x201c;Special Resolution&#x201d;), and pursuant to the Amended and Restated Articles, such actions include amending the Amended and Restated Articles and approving a statutory merger or consolidation with another company. There is no cumulative voting with respect to the appointment of directors, meaning, following the initial Business Combination, the holders of more than 50% of the Ordinary Shares voted for the appointment of directors can elect all of the directors. Prior to the consummation of the initial Business Combination, only holders of the Class&#160;B Ordinary Shares (i)&#160;have the right to vote on the appointment and removal of directors and (ii)&#160;are entitled to vote on continuing the Company in a jurisdiction outside the Cayman Islands (including any Special Resolution required to amend the Amended and Restated Articles or to adopt new constitutional documents, in each case, as a result of the Company approving a transfer by way of continuation in a jurisdiction outside the Cayman Islands). Holders of the Class&#160;A Ordinary Shares are not entitled to vote on these matters during such time. These provisions of the Amended and Restated Articles may only be amended if approved by a Special Resolution passed by the affirmative vote of at least 90% (or, where such amendment is proposed in respect of the consummation of the initial Business Combination, two-thirds) of the votes cast by such shareholders as, being entitled to do so, vote in person or, where proxies are allowed, by proxy at the applicable general meeting of the Company. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Warrants&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; There are 7,532,500 Public Warrants and 221,735 Private Placement Warrants outstanding as of March 31, 2026 and December 31, 2025. Each whole Warrant entitles the holder to purchase one Class A Ordinary Share at a price of $11.50 per share, subject to adjustment as discussed herein. The Warrants cannot be exercised until 30 days after the completion of the initial Business Combination, and will expire at 5:00 p.m., New York City time, five years after the completion of the initial Business Combination or earlier upon redemption or liquidation. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company will not be obligated to deliver any Class&#160;A Ordinary Shares pursuant to the exercise of a Warrant and will have no obligation to settle such Warrant exercise unless a registration statement under the Securities Act with respect to the Class A Ordinary Shares underlying the Warrants is then effective and a prospectus relating thereto is current. No Warrant will be exercisable and the Company will not be obligated to issue a Class&#160;A Ordinary Share upon exercise of a Warrant unless the Class&#160;A Ordinary Share issuable upon such Warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the Warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a Warrant, the holder of such Warrant will not be entitled to exercise such Warrant and such Warrant may have no value and expire worthless. In no event will the Company be required to net cash settle any Warrant. In the event that a registration statement is not effective for the exercised Warrants, the purchaser of a Unit containing such Warrant will have paid the full purchase price for the Unit solely for the Class&#160;A Ordinary Share underlying such Unit.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;Under the terms of the Warrant Agreement, dated June 26, 2025, by and between the Company and Continental (the &#x201c;Warrant Agreement&#x201d;), the Company has agreed that, as soon as practicable, but in no event later than 20&#160;business&#160;days, after the closing of its Business Combination, it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the IPO Registration Statement or a new registration statement covering the registration under the Securities Act of the Class A Ordinary Shares issuable upon exercise of the Warrants and thereafter will use its commercially reasonable efforts to cause the same to become effective within 60&#160;business&#160;days following the initial Business Combination and to maintain a current prospectus relating to the Class&#160;A Ordinary Shares issuable upon exercise of the Warrants until the expiration of the Warrants in accordance with the provisions of the Warrant Agreement. If a registration statement covering the Class&#160;A Ordinary Shares issuable upon exercise of the Warrants is not effective by the sixtieth (60&lt;sup&gt;th&lt;/sup&gt;) business&#160;day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise Warrants on a &#x201c;cashless basis&#x201d; in accordance with Section&#160;3(a)(9)&#160;of the Securities Act or another exemption. Notwithstanding the above, if the Class&#160;A Ordinary Shares are at the time of any exercise of a Warrant not listed on a national securities exchange such that they satisfy the definition of a &#x201c;covered security&#x201d; under Section&#160;18(b)(1)&#160;of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their Public Warrants to do so on a &#x201c;cashless basis&#x201d; in accordance with Section&#160;3(a)(9)&#160;of the Securities Act and, in the event the Company so elects, the Company will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, the Company will use its commercially reasonable efforts to register or qualify the Class A Ordinary Shares under applicable blue sky laws to the extent an exemption is not available.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;If the holders exercise their Public Warrants on a cashless basis, they would pay the warrant exercise price by surrendering the Public Warrants for that number of Class&#160;A Ordinary Shares equal to the quotient obtained by dividing (x)&#160;the product of the number of Class&#160;A Ordinary Shares underlying the Public Warrants, multiplied by the excess of the &#x201c;fair market value&#x201d; of the Class&#160;A Ordinary Shares over the exercise price of the Public Warrants by (y)&#160;the fair market value. The &#x201c;fair market value&#x201d; is the average reported Closing Price (as define below) of the Class&#160;A Ordinary Shares for the 10 trading days ending on the third trading day prior to the date on which the notice of exercise is received by the warrant agent or on which the notice of redemption is sent to the holders of Public Warrants, as applicable.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; &lt;span style="font-weight: bold;"&gt;R&lt;i&gt;edemption of Warrants When the Price per Class&#160;A Ordinary Share Equals or Exceeds $18.00&lt;/i&gt;&lt;/span&gt; &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company may redeem the outstanding Warrants:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top"&gt;&lt;td style="width: 0.25in; text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;in whole and not in part;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top"&gt;&lt;td style="width: 0.25in; text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;at a price of $0.01 per Warrant;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top"&gt;&lt;td style="width: 0.25in; text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;upon a minimum of 30&#160;days&#x2019; prior written notice of redemption; and&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top"&gt;&lt;td style="width: 0.25in"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;if, and only if, the last reported sale price (the &#x201c;Closing Price&#x201d;) of the Class&#160;A Ordinary Shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a Warrant) for any 20&#160;trading&#160;days within a 30-trading&#160;day period commencing at least 30&#160;days after completion of the initial Business Combination and ending on the third&#160;trading&#160;day prior to the date on which the Company sends the notice of redemption to the warrant holders.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt; &lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt; Additionally, if the number of outstanding Class&#160;A Ordinary Shares is increased by a share capitalization payable in Class&#160;A Ordinary Shares, or by a subdivision&#160;of Ordinary Shares or other similar event, then, on the effective date of such share capitalization, subdivision&#160;or similar event, the number of Class&#160;A Ordinary Shares issuable on exercise of each Warrant will be increased in proportion to such increase in the outstanding Ordinary Shares. A rights offering made to all or substantially all holders of Ordinary Shares entitling holders to purchase Class&#160;A Ordinary Shares at a price less than the fair market value will be deemed a share capitalization of a number of Class&#160;A Ordinary Shares equal to the product of (i) the number of Class A Ordinary Shares actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for Class A Ordinary Shares) and (ii) the quotient of (x) the price per Class&#160;A Ordinary Share paid in such rights offering and (y) the fair market value. For these purposes (i)&#160;if the rights offering is for securities convertible into or exercisable for Class A Ordinary Shares, in determining the price payable for Class&#160;A Ordinary Shares, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion and (ii) fair market value means the volume weighted average price of Class A Ordinary Shares as reported during the ten (10) trading&#160;day period ending on the trading day prior to the first date on which the Class A Ordinary Shares trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights. &lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="cref_590850699"
      decimals="0"
      id="ixv-5036"
      unitRef="uref_1643728509">1000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="cref_590850699"
      decimals="4"
      id="ixv-5037"
      unitRef="uref_1624330424">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_325383437"
      decimals="0"
      id="ixv-5038"
      unitRef="uref_1643728509">200000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_325383437"
      decimals="4"
      id="ixv-5039"
      unitRef="uref_1624330424">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_325383437"
      decimals="0"
      id="ixv-5040"
      unitRef="uref_1643728509">443470</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_746723642"
      decimals="0"
      id="ixv-5041"
      unitRef="uref_1643728509">443470</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="cref_325383437"
      decimals="0"
      id="ixv-5042"
      unitRef="uref_1643728509">15065000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="cref_494142625"
      decimals="0"
      id="ixv-5043"
      unitRef="uref_1643728509">20000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="cref_494142625"
      decimals="4"
      id="ixv-5044"
      unitRef="uref_1624330424">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesIssued
      contextRef="cref_494142625"
      decimals="0"
      id="ixv-5045"
      unitRef="uref_1643728509">3877118</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="cref_1373974908"
      decimals="0"
      id="ixv-5046"
      unitRef="uref_1643728509">3877118</us-gaap:CommonStockSharesOutstanding>
    <figxu:SharesIssuableUponConversionAggregate
      contextRef="cref_1780687913"
      decimals="3"
      id="ixv-5047"
      unitRef="uref_1980527220">0.205</figxu:SharesIssuableUponConversionAggregate>
    <us-gaap:CommonStockVotingRights contextRef="cref_68441282" id="ixv-5048">one</us-gaap:CommonStockVotingRights>
    <figxu:VotedAppointmentDirectorsPercentage
      contextRef="cref_2073882789"
      decimals="2"
      id="ixv-5049"
      unitRef="uref_1980527220">0.50</figxu:VotedAppointmentDirectorsPercentage>
    <figxu:AffirmativeVotePercentage
      contextRef="cref_2073882789"
      decimals="2"
      id="ixv-5050"
      unitRef="uref_1980527220">0.90</figxu:AffirmativeVotePercentage>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_1686745824"
      decimals="0"
      id="ixv-5051"
      unitRef="uref_1643728509">7532500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="cref_2104595459"
      decimals="0"
      id="ixv-5052"
      unitRef="uref_1643728509">221735</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
      contextRef="cref_258509850"
      decimals="0"
      id="ixv-5053"
      unitRef="uref_1643728509">1</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="cref_408691691"
      decimals="2"
      id="fc_408691691"
      unitRef="uref_1624330424">11.5</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <figxu:WarrantExercisableTerm contextRef="cref_251878526" id="ixv-5055">P30D</figxu:WarrantExercisableTerm>
    <us-gaap:WarrantsAndRightsOutstandingTerm contextRef="cref_258509850" id="ixv-5056">P5Y</us-gaap:WarrantsAndRightsOutstandingTerm>
    <figxu:ClassOfWarrantsOrRightsRedemptionPricePerShare
      contextRef="cref_718551497"
      decimals="2"
      id="ixv-5057"
      unitRef="uref_1624330424">18</figxu:ClassOfWarrantsOrRightsRedemptionPricePerShare>
    <figxu:ClassOfWarrantsOrRightsRedemptionPricePerShare
      contextRef="cref_1217455353"
      decimals="2"
      id="ixv-5058"
      unitRef="uref_1624330424">0.01</figxu:ClassOfWarrantsOrRightsRedemptionPricePerShare>
    <figxu:ClassOfWarrantOrRightPeriodOfNoticePriorToRedemption contextRef="cref_1217455353" id="ixv-5059">P30D</figxu:ClassOfWarrantOrRightPeriodOfNoticePriorToRedemption>
    <figxu:NewlyAdjustedIssueSharePrice
      contextRef="cref_1217455353"
      decimals="2"
      id="ixv-5060"
      unitRef="uref_1624330424">18</figxu:NewlyAdjustedIssueSharePrice>
    <figxu:NumberOfTradingDaysForDeterminingTheNewlyIssuedSharePrice contextRef="cref_1217455353" id="ixv-5061">P20D</figxu:NumberOfTradingDaysForDeterminingTheNewlyIssuedSharePrice>
    <figxu:NumberOfConsecutiveTradingDaysForDeterminingTheNewlyIssuedSharePrice contextRef="cref_1217455353" id="ixv-5062">P30D</figxu:NumberOfConsecutiveTradingDaysForDeterminingTheNewlyIssuedSharePrice>
    <figxu:NumberOfTradingDaysForDeterminingTheVolumeWeightedAveragePriceOfShares contextRef="cref_2073882789" id="ixv-5063">P10D</figxu:NumberOfTradingDaysForDeterminingTheVolumeWeightedAveragePriceOfShares>
    <us-gaap:FairValueDisclosuresTextBlock contextRef="cref_2073882789" id="ixv-3051">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;8 &#x2014;&#160;Fair Value Measurements&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#x201c;Fair value&#x201d; is defined as the price that would be received for sale of an asset or paid for transfer of a liability in an orderly transaction between market participants at the measurement date. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top"&gt;&lt;td style="width: 0.25in; text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x201c;Level 1&#x201d;, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top"&gt;&lt;td style="width: 0.25in; text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x201c;Level 2&#x201d;, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: top"&gt;&lt;td style="width: 0.25in; text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x201c;Level 3&#x201d;, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. In some circumstances, the inputs used to measure fair value might be categorized within different levels of the fair value hierarchy. In those instances, the fair value measurement is categorized in its entirety in the fair value hierarchy based on the lowest level input that is significant to the fair value measurement.&lt;/span&gt;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;The following table presents information about the Company&#x2019;s assets that are measured at fair value as of March 31, 2026 and December 31, 2025 indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;March 31,&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Level&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="text-align: justify"&gt;Assets:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 64%; text-align: justify"&gt;Investments held in Trust Account&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: center"&gt;1&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;155,087,314&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;153,708,127&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; On the date of the Initial Public Offering (June 30, 2025), the fair value of the Public Warrants was $1,438,708 or $0.191 per Public Warrant. The fair value of Public Warrants was determined using Monte Carlo Simulation Model. The Public Warrants have been classified within shareholders&#x2019; deficit and will not require remeasurement after issuance. The following table presents the quantitative information regarding market assumptions used in the valuation of the Public Warrants: &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;June 30,&lt;br/&gt; 2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 88%; text-align: justify"&gt;Volatility&#x202f;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;5.0&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: justify"&gt;Risk-free rate&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;3.90&lt;/td&gt; &lt;td style="text-align: left"&gt;%&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="text-align: justify"&gt;Stock price&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;9.92&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: justify"&gt;Weighted terms (years)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;7.01&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="cref_2073882789" id="ixv-3084">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;The following table presents information about the Company&#x2019;s assets that are measured at fair value as of March 31, 2026 and December 31, 2025 indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: center"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;March 31,&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center"&gt;December 31,&lt;/td&gt; &lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;Level&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="text-align: justify"&gt;Assets:&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 64%; text-align: justify"&gt;Investments held in Trust Account&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: center"&gt;1&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;155,087,314&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;153,708,127&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_1443541773"
      decimals="0"
      id="ixv-5064"
      unitRef="uref_782852322">155087314</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_318541363"
      decimals="0"
      id="ixv-5065"
      unitRef="uref_782852322">153708127</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:FairValueAdjustmentOfWarrants
      contextRef="cref_1624330424"
      decimals="0"
      id="ixv-5066"
      unitRef="uref_782852322">1438708</us-gaap:FairValueAdjustmentOfWarrants>
    <figxu:PublicWarrants
      contextRef="cref_1624330424"
      decimals="3"
      id="ixv-5067"
      unitRef="uref_1624330424">0.191</figxu:PublicWarrants>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock contextRef="cref_2073882789" id="ixv-5068">The following table presents the quantitative information regarding market assumptions used in the valuation of the Public Warrants:&lt;table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"&gt;June 30,&lt;br/&gt; 2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 88%; text-align: justify"&gt;Volatility&#x202f;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;5.0&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;%&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: justify"&gt;Risk-free rate&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;3.90&lt;/td&gt; &lt;td style="text-align: left"&gt;%&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="text-align: justify"&gt;Stock price&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;9.92&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: justify"&gt;Weighted terms (years)&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="text-align: right"&gt;7.01&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_645954474"
      decimals="3"
      id="ixv-5069"
      unitRef="uref_1980527220">0.05</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_1119542603"
      decimals="4"
      id="ixv-5070"
      unitRef="uref_1980527220">0.039</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_1710269123"
      decimals="2"
      id="ixv-5071"
      unitRef="uref_1980527220">9.92</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:WarrantsAndRightsOutstandingMeasurementInput
      contextRef="cref_1980527220"
      decimals="2"
      id="ixv-5072"
      unitRef="uref_1980527220">7.01</us-gaap:WarrantsAndRightsOutstandingMeasurementInput>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="cref_2073882789" id="ixv-3201">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;9 &#x2014;&#160;Segment Information&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;ASC 280 establishes standards for companies to report in their financial statement information about operating segments, products, services, geographic areas, and major customers. Operating segments are defined as components of an enterprise that engage in business activities from which it may recognize revenues and incur expenses, and for which separate financial information is available that is regularly evaluated by a company&#x2019;s CODM, or group, in deciding how to allocate resources and assess performance.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt; The Company&#x2019;s CODM has been identified as the &lt;span style="-sec-ix-hidden:fc_665619345"&gt;Chief Executive Officer&lt;/span&gt;, who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance. Accordingly, Management has determined that the Company only has one operating segment. &lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The CODM assesses performance for the single segment and decides how to allocate resources. The measure of segment assets is reported on the accompanying condensed balance sheets as total assets. When evaluating the Company&#x2019;s performance and making key decisions regarding resource allocation, the CODM reviews several key metrics, which include the following:&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;March 31, 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;December 31, 2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 76%"&gt;Cash&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;858,098&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;905,141&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left"&gt;Investments held in Trust Account&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;155,087,314&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;153,708,127&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt; &lt;tbody&gt;&lt;tr style="vertical-align: bottom"&gt;&lt;td&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the&lt;br/&gt; Three Months&lt;br/&gt; Ended&lt;br/&gt; March 31,&lt;br/&gt; 2026&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;td style="font-weight: bold; padding-bottom: 1.5pt"&gt;&#160;&lt;/td&gt; &lt;td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center"&gt;For the&lt;br/&gt;  Period from&lt;br/&gt; February     20,&lt;br/&gt; 2025 (Inception) Through&lt;br/&gt; March 31,&lt;br/&gt; 2025&lt;/td&gt; &lt;td style="padding-bottom: 1.5pt; font-weight: bold"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;&lt;td style="width: 76%; text-align: left"&gt;Formation and general and administrative costs&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;156,314&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%"&gt;&#160;&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt; &lt;td style="width: 9%; text-align: right"&gt;30,298&lt;/td&gt; &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;tr style="vertical-align: bottom; background-color: White"&gt;&lt;td style="text-align: left"&gt;Interest earned on investments held in Trust Account&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;1,379,187&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;td&gt;&#160;&lt;/td&gt; &lt;td style="text-align: left"&gt;$&lt;/td&gt; &lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;span style="-sec-ix-hidden:fc_1298709857"&gt;&#x2014;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt; &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt; &lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The key measures of segment profit or loss reviewed by the CODM are formation, general and administrative costs. Formation, general and administrative costs are reviewed and monitored by the CODM to manage and forecast cash to ensure enough capital was available to complete the Initial Public Offering and eventually a Business Combination within the Combination Period. The CODM also reviews formation, general and administrative expenses to manage, maintain and enforce all contractual agreements to ensure costs are aligned with all agreements and budget. Funds invested in the Trust Account represent the predominant portion of the Company&#x2019;s total assets and are monitored by the CODM to determine the most effective strategy of investment with the Trust Account funds, while maintaining compliance with the &lt;span style="background-color: white"&gt;Investment Management Trust Agreement, dated June 26, 2025, which the Company entered into with &lt;/span&gt;Continental, as trustee of the Trust Account.&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The accounting policies used to measure the profit and loss of the segment are the same as those described in the summary of significant accounting policies above under Note 2.&lt;/p&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription contextRef="cref_2073882789" id="ixv-3208">The Company&#x2019;s CODM has been identified as the Chief Executive Officer, who reviews the operating results for the Company as a whole to make decisions about allocating resources and assessing financial performance.</us-gaap:SegmentReportingCodmProfitLossMeasureHowUsedDescription>
    <us-gaap:NumberOfOperatingSegments
      contextRef="cref_2073882789"
      decimals="0"
      id="ixv-5073"
      unitRef="uref_367292527">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:Cash
      contextRef="cref_590850699"
      decimals="0"
      id="ixv-5074"
      unitRef="uref_782852322">858098</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="cref_1744689869"
      decimals="0"
      id="ixv-5075"
      unitRef="uref_782852322">905141</us-gaap:Cash>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_590850699"
      decimals="0"
      id="ixv-5076"
      unitRef="uref_782852322">155087314</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:AssetsHeldInTrustNoncurrent
      contextRef="cref_1744689869"
      decimals="0"
      id="ixv-5077"
      unitRef="uref_782852322">153708127</us-gaap:AssetsHeldInTrustNoncurrent>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_2073882789"
      decimals="0"
      id="ixv-5078"
      unitRef="uref_782852322">156314</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="cref_1165240187"
      decimals="0"
      id="ixv-5079"
      unitRef="uref_782852322">30298</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:InvestmentIncomeInterest
      contextRef="cref_2073882789"
      decimals="0"
      id="ixv-5080"
      unitRef="uref_782852322">1379187</us-gaap:InvestmentIncomeInterest>
    <us-gaap:SubsequentEventsTextBlock contextRef="cref_2073882789" id="ixv-3294">&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&lt;span style="font-weight: bold;"&gt;Note&#160;10&#160;&#x2014;&#160;Subsequent Events&lt;/span&gt;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;&#160;&lt;/p&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"&gt;The Company evaluated subsequent events and transactions that occurred after the accompanying condensed balance sheet date through the date of the issuance of the accompanying unaudited condensed financial statements. Based upon this review, there are no events and transactions that would have required adjustment or disclosure in the accompanying unaudited condensed financial statements.&lt;/p&gt;</us-gaap:SubsequentEventsTextBlock>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="cref_2073882789" id="ixv-5081">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="cref_2073882789" id="ixv-5082">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="cref_2073882789" id="ixv-5083">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="cref_2073882789" id="ixv-5084">false</ecd:NonRule10b51ArrTrmntdFlag>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#fc_864241666"
          xlink:label="fc_864241666"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1268699674"
          xlink:label="fc_1268699674"
          xlink:type="locator"/>
        <link:footnote id="fref_1750563732" xlink:label="fref_1750563732" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The period from February 20, 205 (Inception) through March 31, 2025 excluded up to 491,250 Founder Shares that were subject to forfeiture by the Sponsor for no consideration depending on the extent to which the Over-Allotment Option was exercised (Note 5). On June 30, 2025, the Company consummated the Initial Public Offering of 15,065,000 Public Units at $10.00 per Public Unit, which included the full exercise of the Over-Allotment Option, and the 491,250 Founder Shares were no longer subject to forfeiture</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_864241666"
          xlink:to="fref_1750563732"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1268699674"
          xlink:to="fref_1750563732"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#fc_2081896306"
          xlink:label="fc_2081896306"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_1632373075"
          xlink:label="fc_1632373075"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_912874889"
          xlink:label="fc_912874889"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_871821477"
          xlink:label="fc_871821477"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_694439886"
          xlink:label="fc_694439886"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_96955351"
          xlink:label="fc_96955351"
          xlink:type="locator"/>
        <link:loc
          xlink:href="#fc_2058414422"
          xlink:label="fc_2058414422"
          xlink:type="locator"/>
        <link:footnote id="fref_1612198520" xlink:label="fref_1612198520" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Included up to 491,250 of the Founder Shares that were subject to forfeiture by the Sponsor for no consideration depending on the extent to which the Over-Allotment Option was exercised (Note 5). On June 30, 2025, the Company consummated the Initial Public Offering of 15,065,000 Public Units at $10.00 per Public Unit, which included the full exercise of the Over-Allotment Option, and the 491,250 Founder Shares were no longer subject to forfeiture.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_2081896306"
          xlink:to="fref_1612198520"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_1632373075"
          xlink:to="fref_1612198520"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_912874889"
          xlink:to="fref_1612198520"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_871821477"
          xlink:to="fref_1612198520"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_694439886"
          xlink:to="fref_1612198520"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_96955351"
          xlink:to="fref_1612198520"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="fc_2058414422"
          xlink:to="fref_1612198520"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
